<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">29236</article-id><article-id pub-id-type="doi">10.7554/eLife.29236</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Structural Biology and Molecular Biophysics</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>Rift Valley fever phlebovirus NSs protein core domain structure suggests molecular basis for nuclear filaments</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-90564"><name><surname>Barski</surname><given-names>Michal</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-4663-6915</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/><xref ref-type="fn" rid="pa1">‡</xref></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-65293"><name><surname>Brennan</surname><given-names>Benjamin</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-4707-726X</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-28473"><name><surname>Miller</surname><given-names>Ona K</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2486-7680</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-90563"><name><surname>Potter</surname><given-names>Jane A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-90565"><name><surname>Vijayakrishnan</surname><given-names>Swetha</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-90562"><name><surname>Bhella</surname><given-names>David</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-90566"><name><surname>Naismith</surname><given-names>James H</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-21701"><name><surname>Elliott</surname><given-names>Richard M</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/><xref ref-type="fn" rid="fn3">§</xref></contrib><contrib contrib-type="author" corresp="yes" id="author-27682"><name><surname>Schwarz-Linek</surname><given-names>Ulrich</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-0526-223X</contrib-id><email>us6@st-andrews.ac.uk</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution content-type="dept">Biomedical Sciences Research Complex</institution><institution>University of St Andrews</institution><addr-line><named-content content-type="city">St Andrews</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff2"><label>2</label><institution>MRC-University of Glasgow Centre for Virus Research</institution><addr-line><named-content content-type="city">London</named-content></addr-line><country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1018"><name><surname>Kuriyan</surname><given-names>John</given-names></name><role>Reviewing Editor</role><aff><institution>University of California, Berkeley</institution><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="present-address" id="pa1"><label>‡</label><p>Division of Infectious Diseases, Imperial College London, London, United kingdom</p></fn><fn fn-type="equal" id="fn1"><p><sup>*</sup>Contributed equally to this work</p></fn><fn id="fn2"><p>The authors declare that no competing interests exist.</p></fn><fn fn-type="other" id="fn3"><label>§</label><p>Deceased</p></fn><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>15</day><month>09</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>6</volume><elocation-id>e29236</elocation-id><history><date date-type="received" iso-8601-date="2017-06-02"><day>02</day><month>06</month><year>2017</year></date><date date-type="accepted" iso-8601-date="2017-08-21"><day>21</day><month>08</month><year>2017</year></date></history><permissions><copyright-statement>© 2017, Barski et al</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Barski et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-29236-v1.pdf"/><related-object ext-link-type="url" xlink:href="https://elifesciences.org/articles/e29236v1"><date date-type="v1" iso-8601-date="2017-09-15"><day>15</day><month>09</month><year>2017</year></date></related-object><abstract><object-id pub-id-type="doi">10.7554/eLife.29236.001</object-id><p>Rift Valley fever phlebovirus (RVFV) is a clinically and economically important pathogen increasingly likely to cause widespread epidemics. RVFV virulence depends on the interferon antagonist non-structural protein (NSs), which remains poorly characterized. We identified a stable core domain of RVFV NSs (residues 83–248), and solved its crystal structure, a novel all-helical fold organized into highly ordered fibrils. A hallmark of RVFV pathology is NSs filament formation in infected cell nuclei. Recombinant virus encoding the NSs core domain induced intranuclear filaments, suggesting it contains all essential determinants for nuclear translocation and filament formation. Mutations of key crystal fibril interface residues in viruses encoding full-length NSs completely abrogated intranuclear filament formation in infected cells. We propose the fibrillar arrangement of the NSs core domain in crystals reveals the molecular basis of assembly of this key virulence factor in cell nuclei. Our findings have important implications for fundamental understanding of RVFV virulence.</p></abstract><abstract abstract-type="executive-summary"><object-id pub-id-type="doi">10.7554/eLife.29236.002</object-id><title>eLife digest</title><p>Rift Valley fever phlebovirus (RVFV) is a virus of humans and livestock, transmitted by mosquitos and contact with infected animals. Infection can cause severe disease, including hemorrhagic fever, and may lead to death. Historically, the virus was only found in central Africa but it has spread for instance to the Arabian Peninsula. There is a risk that the virus may appear in temperate regions including Europe because global warming is allowing the mosquitos that carry the virus to extend their geographic range. There are no vaccines or treatments available for use in humans so if there is a serious outbreak of the virus it could become an epidemic and cause great economic losses and severe human disease.</p><p>RVFV relies on a protein called NSs to cause disease. In cells of infected animals and humans NSs forms filaments inside the nucleus, the control center of the cell, and disarms the immune system. However, it is not known precisely how NSs works.</p><p>To address this question, Barski, Brennan et al. used a technique called X-ray crystallography to study the atomic three-dimensional structure of NSs. This revealed that the center of the protein contains a core domain that causes the filaments to form. Further experiments identified how the NSs core comes together to build the filaments inside the cell nucleus.</p><p>These findings represent an important step towards understanding how the NSs protein helps RVFV to cause disease in humans and livestock. In the future, this work may aid the development of much needed drugs and vaccines against RVFV.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>Rift valley fever virus</kwd><kwd>X-ray crystallography</kwd><kwd>virulence factor</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Virus</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000265</institution-id><institution>Medical Research Council</institution></institution-wrap></funding-source><award-id>MDTG11 - MR/J500343/1</award-id><principal-award-recipient><name><surname>Barski</surname><given-names>Michal</given-names></name><name><surname>Schwarz-Linek</surname><given-names>Ulrich</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome</institution></institution-wrap></funding-source><award-id>099220/Z/12/Z</award-id><principal-award-recipient><name><surname>Brennan</surname><given-names>Benjamin</given-names></name><name><surname>Elliott</surname><given-names>Richard M</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000332</institution-id><institution>Royal Society of Edinburgh</institution></institution-wrap></funding-source><award-id>Caledonian Scholarship</award-id><principal-award-recipient><name><surname>Miller</surname><given-names>Ona K</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Insight into the molecular assembly of a protein with a central role in infections paves the way to understanding how Rift Valley fever virus causes disease.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Rift Valley fever phlebovirus (RVFV), of the genus <italic>Phlebovirus</italic>, is one of the most clinically significant members of the <italic>Phenuiviridae</italic> family, of the <italic>Bunyavirales</italic> order (<xref ref-type="bibr" rid="bib19">Elliott and Brennan, 2014</xref>; <xref ref-type="bibr" rid="bib45">Plyusnin et al., 2012</xref>; <xref ref-type="bibr" rid="bib1">Adams et al., 2017</xref>). RVFV is an arbovirus spread by many mosquito vector species as well as by exposure to infected tissues. It causes recurring epidemics in livestock and humans (<xref ref-type="bibr" rid="bib29">Ikegami and Makino, 2011</xref>). The most prominent effect of RVFV infection in ruminants is a high rate of abortions. In humans infections are usually self-limiting, but can develop into hepatitis, retinitis, encephalitis and hemorrhagic fever with fatality rates of 0.5–2% (<xref ref-type="bibr" rid="bib44">Pepin et al., 2010</xref>). Although originally endemic to sub-Saharan Africa, RVFV has recently appeared in Madagascar, the Comoros and the Arabian Peninsula (<xref ref-type="bibr" rid="bib3">Balkhy and Memish, 2003</xref>). Increasing spread of competent mosquito vector species due to climate change could facilitate emergence of this virus in new ecosystems, including Europe and the United States (<xref ref-type="bibr" rid="bib13">Chevalier, 2013</xref>; <xref ref-type="bibr" rid="bib18">Elliott, 2009</xref>; <xref ref-type="bibr" rid="bib24">Golnar et al., 2014</xref>; <xref ref-type="bibr" rid="bib49">Rolin et al., 2013</xref>). In 2017 the World Health Organization ranked RVFV among the ten most dangerous pathogens most likely to cause wide epidemics in the near future, requiring urgent attention (<ext-link ext-link-type="uri" xlink:href="http://www.who.int/blueprint/priority-diseases/en/">http://www.who.int/blueprint/priority-diseases/en/</ext-link>). While an animal vaccine for RVFV exists, there is no treatment available for human use (<xref ref-type="bibr" rid="bib9">Boshra et al., 2011</xref>; <xref ref-type="bibr" rid="bib37">Lihoradova and Ikegami, 2014</xref>).</p><p>RVFV is a zoonotic arbovirus evolved to evade the immune response of mammals and insects. Innate immune antagonism of RVFV is primarily mediated by its main virulence factor, the 30 kDa non-structural protein (NSs), which is transcribed and translated from a subgenomic mRNA derived from the antigenomic S segment early during infection. NSs impedes interferon production through three known mechanisms (<xref ref-type="bibr" rid="bib4">Billecocq et al., 2004</xref>; <xref ref-type="bibr" rid="bib10">Bouloy et al., 2001</xref>). In infected host cells, NSs is transported into the nucleus where it interferes with the assembly of the RNA polymerase II preinitiation complex transcription factor II H (TFIIH) by binding to the p44 subunit (<xref ref-type="bibr" rid="bib34">Le May et al., 2004</xref>) and directing the p62 subunit for degradation (<xref ref-type="bibr" rid="bib30">Kainulainen et al., 2014</xref>; <xref ref-type="bibr" rid="bib31">Kalveram et al., 2011</xref>), thereby halting global cellular transcription. NSs also prevents activation of the interferon-β promoter specifically by binding to factor SAP30, a member of a multisubunit histone deacetylase transcriptional repression complex that regulates interferon-β expression (<xref ref-type="bibr" rid="bib35">Le May et al., 2008</xref>). Furthermore, NSs blocks host recognition of viral dsRNA by targeting the RNA-dependent protein kinase (PKR) for degradation (<xref ref-type="bibr" rid="bib27">Ikegami et al., 2009a</xref>, <xref ref-type="bibr" rid="bib28">2009b</xref>). RVFV with a deletion of NSs cannot establish viremia and is not pathogenic in the mouse model (<xref ref-type="bibr" rid="bib10">Bouloy et al., 2001</xref>).</p><p>A characteristic feature of RVFV pathogenesis is formation of 0.5 μm thick proteinaceous filaments formed by bundles of thin fibrils in the nuclei of infected cells (<xref ref-type="bibr" rid="bib52">Swanepoel and Blackburn, 1977</xref>). The filaments are composed primarily of NSs protein (<xref ref-type="bibr" rid="bib51">Struthers and Swanepoel, 1982</xref>; <xref ref-type="bibr" rid="bib59">Yadani et al., 1999</xref>) but co-localize with p44, XPB, SAP30 and YY1, as well (<xref ref-type="bibr" rid="bib34">Le May et al., 2004</xref>, <xref ref-type="bibr" rid="bib35">2008</xref>). It is not clear if filament formation is required for NSs function, that is if any interaction sites are present on the monomeric form of the protein, or are only present in the multimerized, fibrillar NSs. In the absence of structural information it is difficult to dissect NSs function from filament formation. Potential functions of nuclear NSs filaments include sequestering NSs binding partners, causing cell cycle arrest and defects in chromosome cohesion and segregation (<xref ref-type="bibr" rid="bib41">Mansuroglu et al., 2010</xref>). This could contribute to the high rate of fetal deformities and abortions observed in RVFV-infected ruminants (<xref ref-type="bibr" rid="bib2">Baer et al., 2012</xref>; <xref ref-type="bibr" rid="bib41">Mansuroglu et al., 2010</xref>).</p><p>NSs proteins are encoded in the S segment of the tripartite negative sense single strand RNA genome of most members of the <italic>Phlebovirus</italic> genus, and other families of the <italic>Bunyavirales</italic> order such as the <italic>Peribunyaviridae</italic>, <italic>Nairoviridae</italic>, and some members of the <italic>Hantaviridae</italic> (<xref ref-type="bibr" rid="bib40">Ly and Ikegami, 2016</xref>). They constitute notoriously difficult targets for structural characterization due to an inherent tendency to multimerize, as well as the putative presence of substantial intrinsically unfolded regions. While high-resolution structures of glycoproteins (<xref ref-type="bibr" rid="bib16">Dessau and Modis, 2013</xref>) and nucleoproteins (<xref ref-type="bibr" rid="bib22">Ferron et al., 2011</xref>; <xref ref-type="bibr" rid="bib47">Raymond et al., 2010</xref>) from RVFV and several other bunyaviruses have been determined, no structural information is currently available for any NSs protein, significantly limiting the current understanding of key bunyaviral virulence mechanisms. Structure and function can also not be predicted based on sequence, as NSs proteins are ‘ORFans’, with very little sequence similarity in members of the <italic>Bunyavirales</italic> order and the <italic>Phlebovirus</italic> genus. Despite large sequence diversity, NSs proteins examined thus far have been found to play roles in the suppression of the host innate immune response. However, this and the diverse mechanisms of NSs function have been studied only for a few viruses.</p><p>Here we describe the first high-resolution structure of a bunyaviral NSs protein. A truncated stable, soluble core domain spanning residues 83–248 of RVFV NSs (NSs-ΔNΔC) was identified using NMR spectroscopy. The corresponding crystal structure represents a novel all-helical fold. Notably, NSs molecules packed in crystals in double-helical fibrils stabilized by multiple interfaces. Dimensions of these fibrils are in good agreement with fibrils constituting nuclear NSs filaments in RVFV-infected cells. Cells infected with recombinant RVFV encoding NSs-ΔNΔC produced nuclear filaments indistinguishable from filaments observed in cells infected with parental RVFV. Furthermore, recombinant viruses encoding full-length NSs with mutations predicted to destabilize significant fibril interfaces, as suggested by crystal packing, did not induce nuclear filaments. Combination of structural biology with cell infection assays using reverse genetics to tailor the main RVFV virulence factor identified a RVFV NSs core domain sufficient for filament formation in vivo, and revealed the structural basis for NSs nuclear filament formation.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>NSs contains a stable central core and a disordered C-terminal tail</title><p>Full-length NSs protein (residues 1–265) was expressed as a cleavable MBP fusion yielding only a small amount (about 0.1 mg per litre of culture) of soluble protein after removal of MBP. Circular dichroism spectroscopy showed secondary and tertiary structure in mature NSs (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>), however the protein formed large soluble aggregates, eluting in the void volume of size exclusion chromatography (mass over 200 kDa) (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). This construct was therefore redesigned in order to obtain a stable, non-aggregating and soluble fragment of NSs. Secondary structure predictions suggested an N-terminal region with a propensity to form β sheet structure (residues 1–70), connected by an unstructured linker to a central α-helical domain (85-230). The C-terminal region was predicted to be natively unfolded (231-265). Deletion of the N-terminal 82 amino acids (resulting in truncated NSs hereafter referred to as NSs-ΔN, residues 83–265) significantly improved expression yields, solubility and stability. In solution, the NSs-ΔN protein existed in equilibrium between monomeric and multimeric forms (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Near-UV CD spectra indicated a helical protein, with characteristic minima at 208 and 220 nm (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>).</p><fig-group><fig id="fig1" position="float"><object-id pub-id-type="doi">10.7554/eLife.29236.003</object-id><label>Figure 1.</label><caption><title>(<bold>A</bold>) Size exclusion chromatography elution traces of recombinantly expressed NSs variants, detected by UV absorption at 280 nm.</title><p>Elution volumes for molecular mass markers used for calibration of the column are indicated with dashed lines. (<bold>B</bold>) <sup>1</sup>H-<sup>15</sup>N HSQC NMR spectra of NSs-ΔN (blue) and NSs-ΔNΔC (red) overlaid. The right-hand panel shows the central region of the spectra plotted at high contour levels, selecting a subset of intense crosspeaks representing highly dynamic amino acid residues, most of which are not present in NSs-ΔNΔC. The dashed line connects crosspeaks of one side-chain amide.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-29236-fig1-v1"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.29236.004</object-id><label>Figure 1—figure supplement 1.</label><caption><title>CD spectra of NSs.</title><p>(<bold>A</bold>) Far-UV CD spectrum of FL-NSs. (<bold>B</bold>) Far-UV CD spectrum of NSs-ΔN. (<bold>C</bold>) Near-UV CD of FL-NSs shows a weak but distinctive signal (blue) as compared with buffer (green), indicating presence of tertiary structure. (<bold>D</bold>) Near-UV CD of NSs-ΔN (blue), NSs-ΔNΔC (maroon) and buffer (green). Matching minima and maxima observed in spectra of all three NSs variants are indicated by colored arrows.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-29236-fig1-figsupp1-v1"/></fig></fig-group><p>NSs-ΔN was highly soluble (up to 30 mg/mL) in near-physiological buffer conditions. A 2D <sup>1</sup>H-<sup>15</sup>N heteronuclear single-quantum coherence (HSQC) NMR spectrum showed well-dispersed crosspeaks, indicative of folded, monomeric protein (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). The central region of the spectrum, spanning chemical shifts of 7.5 to 8.5 ppm in the <sup>1</sup>H dimension, was dominated by 17 intense and narrow backbone amide signals, indicating significant flexibility of corresponding residues. Based on secondary structure and disorder predictions, we concluded the intrinsically unfolded residues were present at the C-terminus of NSs-ΔN. Subsequent removal of the C-terminal 17 amino acids (resulting in doubly truncated NSs hereafter referred to as NSs-ΔNΔC, residues 83–248) yielded protein present as a monomer in solution (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Its <sup>1</sup>H-<sup>15</sup>N HSQC spectrum was devoid of all but two intense crosspeaks observed for NSs-ΔN (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). All other signals overlapped well with crosspeaks in the NSs-ΔN spectrum, indicating absence of residues 249–265 does not influence the structure of NSs-ΔNΔC.</p></sec><sec id="s2-2"><title>Crystal structure shows the NSs core domain adopts a novel fold</title><p>The NSs-ΔNΔC protein was crystallized at conditions optimized following routine sparse-matrix crystallization screens. The crystals were found to be extremely fragile, and diffracted synchrotron X-rays to 2.2 Å resolution. Crystals belonged to space group <italic>P</italic>6<sub>4</sub>22. Calculation of the Matthews coefficient indicated a high solvent content of 76%, assuming two molecules in the asymmetric unit. Due to the absence of any molecular replacement models, experimental phasing had to be undertaken. Because of the higher-than-average sulfur content of NSs-ΔNΔC (12 sulfurs per chain of 175 residues) and the highly symmetrical <italic>P</italic>6<sub>4</sub>22 space group of the crystals, S-SAD phasing was pursued. The structure was successfully phased from the anomalous sulfur signal in a single native crystal and refined to high quality (<xref ref-type="table" rid="table1">Table 1</xref>).</p><table-wrap id="table1" position="float"><object-id pub-id-type="doi">10.7554/eLife.29236.005</object-id><label>Table 1.</label><caption><title>Data collection and refinement statistics</title></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="2"><bold>Data collection</bold></th></tr></thead><tbody><tr><td>Space group</td><td><italic>P</italic>6<sub>4</sub>22</td></tr><tr><td>Cell dimensions a, b, c (Å) <break/>α, β, γ (°)</td><td>123.8, 123.8, 174.0 <break/>90, 90, 120</td></tr><tr><td>Beamline</td><td>Diamond i03</td></tr><tr><td>Wavelength (Å)</td><td>2.0</td></tr><tr><td>Resolution (Å)</td><td>107.83–2.19 (2.25–2.19)</td></tr><tr><td>Number of observed reflections</td><td>1877448</td></tr><tr><td>Number of unique reflections</td><td>41684</td></tr><tr><td>Completeness (%)</td><td>99.9 (99.9)</td></tr><tr><td>R<sub>merge</sub> (%) *</td><td>9.8 (223.4)</td></tr><tr><td>I/δ</td><td>32.3 (1.6)</td></tr><tr><td>Multiplicity</td><td>45.0 (18.2)</td></tr><tr><td>Anomalous completeness (%)</td><td>99.9 (99.8)</td></tr><tr><td>Anomalous multiplicity</td><td>23.7 (9.4)</td></tr><tr><td>Anomalous slope</td><td>1.169</td></tr><tr><td colspan="2"><bold>Refinement statistics</bold></td></tr><tr><td> R<sub>work</sub> (%) †</td><td>20.1</td></tr><tr><td> R<sub>free</sub> (%) ‡</td><td>21.6</td></tr><tr><td> Ramachandran favored (%)</td><td>97.24</td></tr><tr><td> Ramachandran allowed (%)</td><td>99.08</td></tr><tr><td> MolProbity score/percentile §</td><td>1.61/97</td></tr><tr><td> Averaged B-factor (Å<sup>2</sup>)</td><td>63.47</td></tr><tr><td> Rmsd bond length (Å)</td><td>0.905</td></tr><tr><td> Rmsd bond angles (°)</td><td>1.007</td></tr></tbody></table><table-wrap-foot><fn><p>The values in parenthesis refer to the highest resolution shell.</p><p><sup>*</sup><inline-formula><mml:math id="inf1"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mi>h</mml:mi><mml:mi>k</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">|</mml:mo></mml:mrow><mml:mi>I</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>h</mml:mi><mml:mi>k</mml:mi><mml:mi>l</mml:mi><mml:mo>;</mml:mo><mml:mi>i</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>−</mml:mo><mml:mo>&lt;</mml:mo><mml:mi>I</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>h</mml:mi><mml:mi>k</mml:mi><mml:mi>l</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>&gt;</mml:mo><mml:mrow><mml:mo stretchy="false">|</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:msub><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mi>h</mml:mi><mml:mi>k</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>h</mml:mi><mml:mi>k</mml:mi><mml:mi>l</mml:mi><mml:mo>;</mml:mo><mml:mi>i</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mfrac></mml:mrow></mml:mstyle></mml:math></inline-formula> where <inline-formula><mml:math id="inf2"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>I</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>h</mml:mi><mml:mi>k</mml:mi><mml:mi>l</mml:mi><mml:mo>;</mml:mo><mml:mi>i</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mstyle></mml:math></inline-formula> is the intensity of an individual measurement of a reflection and <inline-formula><mml:math id="inf3"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mo>&lt;</mml:mo><mml:mi>I</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>h</mml:mi><mml:mi>k</mml:mi><mml:mi>l</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>&gt;</mml:mo></mml:mrow></mml:mstyle></mml:math></inline-formula> is the average intensity of that reflection.</p></fn><fn><p><sup>†</sup><inline-formula><mml:math id="inf4"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mrow><mml:mi>w</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mi>h</mml:mi><mml:mi>k</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>F</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>−</mml:mo><mml:msub><mml:mi>F</mml:mi><mml:mi>c</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mi>h</mml:mi><mml:mi>k</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>F</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:mfrac></mml:mrow></mml:mstyle></mml:math></inline-formula> where <inline-formula><mml:math id="inf5"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>F</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mspace width="thinmathspace"/><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>d</mml:mi><mml:mspace width="thinmathspace"/><mml:msub><mml:mi>F</mml:mi><mml:mi>c</mml:mi></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> are the observed and calculated structure factors, respectively.</p><p>‡ R<sub>free</sub> is R<sub>work</sub> with 5% of the observed reflections removed before refinement.</p></fn><fn><p>§ MolProbity score combines the clashscore, rotamer, and Ramachandran evaluations into a single score, normalized to be on the same scale as X-ray resolution. 100th percentile is the best among structures of comparable resolution; 0th percentile is the worst. For clashscore the comparative set of structures was selected in 2004, for MolProbity score in 2006 (<xref ref-type="bibr" rid="bib12">Chen et al., 2010</xref>).</p></fn></table-wrap-foot></table-wrap><p>The NSs-ΔNΔC monomer, molecular mass 19,029 Da, measures approximately 30 × 30 × 50 Å. It is composed of eight α-helices with helices α1-α6 and α8 arranged around a long central helix α7. Two short 3<sub>10</sub> helices are also present (<xref ref-type="fig" rid="fig2">Figure 2</xref>). Residues 234–244 are devoid of secondary structure and traverse approximately 30 Å of the NSs surface, packed against helices α3 and α7. Two NSs-ΔNΔC monomers constitute the asymmetric unit, with an interface formed by their α8 helices (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). There was no visible electron density for the first N-terminal and the five C-terminal amino acids; these residues are unaccounted for in the crystal structure.</p><fig-group><fig id="fig2" position="float"><object-id pub-id-type="doi">10.7554/eLife.29236.006</object-id><label>Figure 2.</label><caption><title>Structure of RVFV NSs-ΔNΔC.</title><p>The helical arrangement of NSs shows a novel fold, comprised mainly of eight α-helices. The protein chain is colored in a rainbow spectrum from the N-terminus to the C-terminus. At the bottom, secondary structure elements are matched with the sequence of NSs-ΔNΔC (residues 83–248 of NSs). Numbered cylinders represent α-helices; narrower cylinders represent 3<sub>10</sub> helices. Residues 244–248 are not defined in the crystal structure.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-29236-fig2-v1"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.29236.007</object-id><label>Figure 2—figure supplement 1.</label><caption><title>Asymmetric unit formed by two NSs molecules (colors as in <xref ref-type="fig" rid="fig2">Figure 2</xref>).</title><p>The bottom image shows the asymmetric unit in the context of the interface between F1 and F2 fibrils.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-29236-fig2-figsupp1-v1"/></fig></fig-group><p>Structural similarity searches with PDBeFold (<xref ref-type="bibr" rid="bib32">Krissinel and Henrick, 2004</xref>) and DALI (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_013433">SCR_013433</ext-link>) (<xref ref-type="bibr" rid="bib26">Holm and Rosenström, 2010</xref>) did not identify significant structural homologues. We therefore conclude the NSs-ΔNΔC structure represents a novel fold.</p></sec><sec id="s2-3"><title>NSs-ΔNΔC in the crystal forms helical fibrils that are stabilized by extensive interfaces</title><p>In the crystal lattice NSs-ΔNΔC molecules were found to pack into a highly organized network of two fibril-like assemblies, referred to here as F1 and F2 (<xref ref-type="fig" rid="fig3">Figure 3</xref>), creating large solvent channels. The F1 and F2 crisscross pattern is produced by F1 fibrils running in parallel to each other and the longest unit cell edge, while F2 fibrils are oriented at an angle of 60° with respect to each other, perpendicular to F1 (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). F1 and F2 fibrils themselves are best described as being composed of repeating NSs tetramer units. Four different, partially overlapping (or alternative) tetramers T1, T2, T3 and T4 can be distinguished that differ in stability and interface areas, according to PISA interface analyses (<xref ref-type="bibr" rid="bib33">Krissinel and Henrick, 2007</xref>), with T1 being the most stable tetramer (<xref ref-type="table" rid="table2">Table 2</xref>). F1 is an assembly of T1 tetramers stacked at 60° angles, while F2 is composed of alternating T1 and T2 tetramers arranged at 90° angles with respect to each other. The T1 interface that lies parallel to the F1 fibril is largely determined by hydrophobic packing of the α6 helices. The T1 interface perpendicular to the F1 fibril axis is defined by an extensive network of hydrogen bonds and salt bridges between the basic face of α1 (Lys84, Gln87, Arg88) and the acidic face of α8 (Glu220, Glu221, Ser228), leading to a large buried interface area of 4 × 852 Å<sup>2</sup> (<xref ref-type="fig" rid="fig4">Figure 4</xref>). The superficially very similar tetramer T2 in F2 fibrils is less stable. Here the molecules are rotated by about 8° with respect to the orientation of the equivalent monomers in T1, and form a twisted tetramer (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). The register of the α6-α6 interface is shifted, decreasing the buried surface area by 169 Å<sup>2</sup> compared to the same interface in T1. The total buried surface area is nearly 1000 Å<sup>2</sup> (17%) smaller in T2 than in T1. The B factors for T2 are also notably higher than for T1, suggesting that interfaces in T1, and therefore F1, possess a higher degree of conformational order, contributing to a higher stability of this assembly (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplements 1</xref>,<xref ref-type="fig" rid="fig4s2">2</xref>). B factors have been used to distinguish biologically relevant interfaces from crystal packing interfaces, which have been found to be characterized by relatively high B factors (<xref ref-type="bibr" rid="bib39">Liu et al., 2014</xref>).</p><fig-group><fig id="fig3" position="float"><object-id pub-id-type="doi">10.7554/eLife.29236.008</object-id><label>Figure 3.</label><caption><title>Crystal packing of NSs-ΔNΔC.</title><p>(<bold>A</bold>) Two fibrillar arrangements, F1 and F2, result from assemblies of alternative tetramers. Two F1 fibrils (vertical) are shown with alternating shades of red for individual molecules. One F2 fibril (horizontal) is shown with alternating shades of gray for individual molecules in F2-specific tetramers (T2, T4). F2 fibrils emerge from each F1 tetramer (T1) but for clarity only two F2 (gray) NSs-ΔNΔC molecules are shown at each node. F2 units are shown in transparent mode on the right hand side F1 fibril to highlight the architecture of F1 fibrils. (<bold>B</bold>) The F1 fibril is a double helix of NSs-ΔNΔC monomers with 2-fold symmetry around the fibril axis and 6 molecules per 180° turn. A section of the F1 fibril containing five T1 tetramers is shown. One half of the double helix resulting from tetramer stacking is rainbow-colored, the other half is shown in shades of grey. (<bold>C</bold>) A simplified representation of a node between F1 and F2 fibrils highlights the architecture of F1 and F2 fibrils and the four different tetramers T1-T4.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-29236-fig3-v1"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.29236.009</object-id><label>Figure 3—figure supplement 1.</label><caption><title>Molecular packing in the NSs-ΔNΔC crystal lattice (wall-eye stereo image).</title><p>T1 and T2 tetramers are shown in red and gray surface representation, respectively. Parallel F1 fibers (indicated by red rods) are perpendicular to F2 fibers (indicated by gray rods) which are arranged at 60° angles with respect to each other.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-29236-fig3-figsupp1-v1"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.29236.010</object-id><label>Figure 3—figure supplement 2.</label><caption><title>Model of a full-length NSs fibril with the NSs-ΔNΔC F1 assembly as core (shown in surface representation).</title><p>The C-terminal extensions are modeled in as natively unfolded regions in random orientations (red sticks). N-terminal regions are shown as blue transparent spheres.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-29236-fig3-figsupp2-v1"/></fig><fig id="fig3s3" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.29236.011</object-id><label>Figure 3—figure supplement 3.</label><caption><title>Accessibility of the α8 helix (red) in F1 and F2 fibrillar crystal assemblies.</title><p>The helix is partially buried at the T1-T2 interface in F2.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-29236-fig3-figsupp3-v1"/></fig></fig-group><fig-group><fig id="fig4" position="float"><object-id pub-id-type="doi">10.7554/eLife.29236.012</object-id><label>Figure 4.</label><caption><title>Interaction interfaces within the F1 and F2 fibrils observed in the NSs-ΔNΔC crystal.</title><p>In the overview of an F1/F2 node (top right) key interface residues targeted by mutagenesis are shown as cyan, yellow and lime spheres for interfaces in T1, T3 and T4, respectively. Expanded regions highlight the residues involved in the three different interfaces. H-bond networks and salt bridges (dashed black lines) stabilize the interfaces for T3 and T1. The α8-α8 interface in T4 is defined by hydrophobic interactions. Residues changed by mutagenesis are marked by asterisks.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-29236-fig4-v1"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.29236.013</object-id><label>Figure 4—figure supplement 1.</label><caption><title>Comparison of T1 and T2 tetramers.</title><p>The ribbon diagrams are rainbow colored according to B factors. The α5-α6 loop is not visible in the crystal structure for the T2 assembly.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-29236-fig4-figsupp1-v1"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.29236.014</object-id><label>Figure 4—figure supplement 2.</label><caption><title>B-factor distribution in the NSs fibrillar crystal assembly.</title></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-29236-fig4-figsupp2-v1"/></fig></fig-group><table-wrap id="table2" position="float"><object-id pub-id-type="doi">10.7554/eLife.29236.015</object-id><label>Table 2.</label><caption><title>Summary of PISA analyses of buried surface areas and ΔG values of the four unique NSs-ΔNΔC tetramers present in the crystal lattice. ΔG<sup>sol</sup> and ΔG<sup>diss</sup> are free energy of solvation (negative values indicate favorable process), and free energy of dissociation of assembly (positive values indicate stable association), respectively.</title></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>Buried surface [Å<sup>2</sup>]</th><th>ΔG<sup>sol</sup> [kcal/mol]</th><th>ΔG<sup>diss</sup> [kcal/mol]</th></tr></thead><tbody><tr><td>T1</td><td>5631</td><td>−33.1</td><td>10.6</td></tr><tr><td>T2</td><td>4654</td><td>−26.4</td><td>1.6</td></tr><tr><td>T3</td><td>4358</td><td>−25.2</td><td>−3.0</td></tr><tr><td>T4</td><td>4892</td><td>−23.9</td><td>2.6</td></tr></tbody></table></table-wrap><p>NSs-ΔNΔC T1 tetramers align at 60° angles in the F1 fibril, held by a network of hydrogen bonds clustered around the loop between helices α5-α6 (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). The 60° turn produces a left-handed double helix with twelve monomers per turn and a 34.8 nm pitch (<xref ref-type="fig" rid="fig3">Figure 3</xref>).</p></sec><sec id="s2-4"><title>The architecture of NSs filaments in cells infected with RVFV</title><p>To gain insight into the architecture of nuclear NSs filaments, we infected Vero-E6 cells with the recombinantly produced parental RVFV strain MP12 as previously described (<xref ref-type="bibr" rid="bib5">Billecocq et al., 2008</xref>; <xref ref-type="bibr" rid="bib11">Brennan et al., 2014</xref>) and imaged cell nuclei containing filaments with transmission electron microscopy (TEM). Thick filaments of NSs, 0.5–1 μm in diameter, started forming about four hours post-infection and averaged to 1–2 filaments per nucleus. TEM reveals a substructure of these filaments (<xref ref-type="fig" rid="fig5">Figure 5</xref>). They appear to be composed of a bundle of tightly packed, extended parallel fibrils with diameters roughly ranging from 8 to 15 nm.</p><fig id="fig5" position="float"><object-id pub-id-type="doi">10.7554/eLife.29236.016</object-id><label>Figure 5.</label><caption><title>TEM observations of fibrils formed in the nuclei of cells infected with RVFV.</title><p>The outline of an NSs filament within a cell nucleus is indicated in the left panel by red arrowheads. Higher magnifications (middle and right panels) reveal a substructure of NSs filaments, which are composed of bundles of parallel fibrils with estimated widths of 8–15 nm. Cyan arrowheads in the right panel indicate one fibril with a width of 10 nm.</p></caption><graphic mime-subtype="png" mimetype="image" xlink:href="elife-29236-fig5-v1"/></fig></sec><sec id="s2-5"><title>Recombinant RVFV expressing NSs-ΔNΔC forms filaments in live cell nuclei</title><p>Recombinant RVFV encoding NSs-ΔNΔC (rMP12NSsΔNΔC) was rescued. Working stock of recombinant virus achieved similar titers (1.15 × 10<sup>8</sup> pfu/mL) to parental MP12 (2.00 × 10<sup>8</sup> pfu/mL) and no difference in plaque morphology was observed. Reverse transcription PCR analysis was performed to confirm the presence of the NSs truncation. Vero-E6 cells were infected with the recombinant rMP12NSsΔNΔC strain. Twenty-four hours after infection NSs-specific immunofluorescence staining showed prominent filaments in nuclei of infected cells (<xref ref-type="fig" rid="fig6">Figure 6</xref>). The morphology of these NSs-ΔNΔC filaments was indistinguishable from structures observed for the parental MP12 strain encoding full-length NSs. Fibrillation was observed only in about 30% of cells infected with rMP12NSsΔNΔC, compared to occurrence of filaments in nearly all cells infected with parental virus.</p><fig id="fig6" position="float"><object-id pub-id-type="doi">10.7554/eLife.29236.017</object-id><label>Figure 6.</label><caption><title>Intracellular localization of NSs in rMP12- or rMP12NSs-ΔNΔC-infected Vero-E6 cells.</title><p>Cells were fixed 24 h p.i. and co-stained with either anti-N or anti-NSs antibodies (green) as indicated and DAPI (blue).</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-29236-fig6-v1"/></fig></sec><sec id="s2-6"><title>Engineering of interfaces observed in NSs-ΔNΔC crystals prevents NSs filament formation in infected cells</title><p>To test if the fibrillar crystal packing observed for NSs-ΔNΔC represents a biologically relevant assembly underpinning intranuclear NSs filament formation, combinations of two key residues in three different crystal interfaces were mutated (<xref ref-type="fig" rid="fig4">Figure 4</xref>). Residues were chosen that were predicted to be critical for assembly of tetramers present in both or either F1 and F2 fibrils, but not essential for monomer stability. Three NSs variants were generated: NSs-ΔNΔC-muT1 (Arg88Asp, Ser228Ala), NSs-ΔNΔC-muT3 (Lys150Gly, Thr152Gly) and NSs-ΔNΔC-muT4 (Ile216Asp, Met219Ala). Disruption of the polar T1 interface, perpendicular to F1, would interrupt both T1 and T2, and therefore F1 and F2. Residue Arg88, forming two salt bridges to Glu220 and Glu221, was mutated to an aspartate. Ser228, forming a side-chain hydrogen bond with Gln87, was replaced by alanine. The T3 interface, unique to F1, was targeted through replacement of Lys150 and Thr152 with glycines. The hydrophobic T4 interface, formed by the α8 helices of the two molecules in the asymmetric unit of the crystals, is unique to F2; it was changed by mutating Ile216 to aspartate and Met219 to alanine. These two residues contribute about 50% of the total buried surface area to the α8-α8 interface.</p><p>NMR spectroscopy was used to assess the effect of these mutations on the folded state of NSs-ΔNΔC in solution. <sup>1</sup>H spectra agreed with conservation of structure in all mutated proteins (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>). All spectra showed the same signal dispersion and no indications of significant changes in structure, such as partial unfolding. High-field shifted methyl signals between −1 and 0 ppm were observed at the same chemical shifts in all spectra. Such signals belong to buried aliphatic side-chains, and conservation of their chemical shifts reflects preservation of the hydrophobic packing in the protein variants.</p><p>Three recombinant viruses encoding full-length NSs containing interface mutations were rescued, rMP12muT1NSs, rMP12muT3NSs, and rMP12muT4NSs. Recombinant viruses grew to similar titers to that of the parental virus rMP12 and had indistinguishable plaque morphologies. Segment specific RT-PCR followed by Sanger sequencing was used to confirm the genomic composition of recombinant viruses. NSs-specific immunofluorescence staining showed the presence of filaments in nuclei of rMP12mut4NSs infected Vero-E6 cells (<xref ref-type="fig" rid="fig7">Figure 7</xref>). In contrast, no filaments were observed in nuclei of cells infected with rMP12muT1NSs and rMP12muT3NSs. In both cases NSs was detected as speckles or diffusely dispersed throughout the nuclei (<xref ref-type="fig" rid="fig7">Figure 7</xref>). These data indicate that all three NSs variants had retained the ability to be imported into nuclei. Mutating interfaces observed in the F1 crystal fibril clearly affected intranuclear NSs filament formation, whereas mutating an interface unique to the F2 fibril did not. Therefore, we conclude that the F1 crystal fibril is not only more stable than F2, but that it also represents the architecture of NSs in intranuclear filaments.</p><fig-group><fig id="fig7" position="float"><object-id pub-id-type="doi">10.7554/eLife.29236.018</object-id><label>Figure 7.</label><caption><title>Intracellular localization of NSs in Vero-E6 cells infected with rMP12 or rMP12 variants encoding NSs variants with interface residue mutations (muT1, muT3, muT4).</title><p>Cells were fixed 24 h p.i. and co-stained with either anti-N or anti-NSs antibodies (green) as indicated and DAPI (blue).</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-29236-fig7-v1"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.29236.019</object-id><label>Figure 7—figure supplement 1.</label><caption><title>1D 1 hr NMR spectra of NSs-ΔNΔC and interface mutation variants.</title><p>Asterisks indicate distinct high-field shifted methyl resonances with conserved chemical shifts in all variants.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-29236-fig7-figsupp1-v1"/></fig></fig-group></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Innate immune antagonism is a common function of many viral non-structural proteins (<xref ref-type="bibr" rid="bib46">Randall and Goodbourn, 2008</xref>), including NSs proteins from bunyaviruses (<xref ref-type="bibr" rid="bib57">Walter and Barr, 2011</xref>). Non-structural viral proteins have been previously structurally characterized, such as the NS1 protein of influenza virus (<xref ref-type="bibr" rid="bib8">Bornholdt and Prasad, 2008</xref>; <xref ref-type="bibr" rid="bib38">Liu et al., 1997</xref>), VP35 of Ebola virus (<xref ref-type="bibr" rid="bib36">Leung et al., 2009</xref>) or NS5A from hepatitis C virus (<xref ref-type="bibr" rid="bib23">Feuerstein et al., 2012</xref>; <xref ref-type="bibr" rid="bib53">Tellinghuisen et al., 2005</xref>). These studies have contributed to understanding both viral pathology and the innate immune system.</p><p>The NSs protein is the main virulence factor of RVFV and most bunyaviruses. RVFV lacking NSs cannot inhibit the interferon response and causes asymptomatic infection in mice (<xref ref-type="bibr" rid="bib10">Bouloy et al., 2001</xref>; <xref ref-type="bibr" rid="bib42">Muller et al., 1995</xref>; <xref ref-type="bibr" rid="bib55">Vialat et al., 2000</xref>). Naturally occurring RVFV clone 13 encoding NSs lacking residues 16–198 (<xref ref-type="bibr" rid="bib42">Muller et al., 1995</xref>), and a recombinant virus deficient of NSs, are currently candidates for live-attenuated vaccines for RVFV (<xref ref-type="bibr" rid="bib6">Bird et al., 2008</xref>; <xref ref-type="bibr" rid="bib7">Bird et al., 2011</xref>). The mode of action of RVFV NSs is understood to an extent. Several binding partners have been identified, and models for NSs function proposed (<xref ref-type="bibr" rid="bib40">Ly and Ikegami, 2016</xref>). The underlying mechanisms of these interactions are however unknown, arguably because so far NSs proteins have largely evaded molecular and structural characterization. Here we report the first structure of a bunyaviral NSs protein.</p><p>Recombinant full-length RVFV NSs was found to form large aggregates in solution, and was not suitable for NMR or crystallography. Therefore, we designed a stable construct amenable to crystallization through double deletion of 82 N-terminal and 17 C-terminal residues (NSs-ΔNΔC). Both these regions had previously been linked to biological functions of NSs, particularly its intranuclear localization and fibrillation (<xref ref-type="bibr" rid="bib59">Yadani et al., 1999</xref>; <xref ref-type="bibr" rid="bib4">Billecocq et al., 2004</xref>; <xref ref-type="bibr" rid="bib14">Cyr et al., 2015</xref>). However, we demonstrate that a recombinant virus containing NSs-ΔNΔC successfully induces filament assembly in nuclei of infected cells (<xref ref-type="fig" rid="fig6">Figure 6</xref>), indicating neither the truncated N- or C-terminal regions are required for fibrillation.</p><p>NSs does not contain any nuclear localization signals, thus nuclear import likely relies on host proteins such as the p44 subunit of the TFIIH transcription complex (<xref ref-type="bibr" rid="bib34">Le May et al., 2004</xref>). Interaction sites for any such binding partners are predicted to be near the N-terminus, since mutation of a PxxP putative protein interaction motif (residues 29–32) results in retention of NSs in the cytoplasm (<xref ref-type="bibr" rid="bib4">Billecocq et al., 2004</xref>). Our data, however, show that the N-terminal 82 residues of NSs (including the 29–32 motif) are dispensable for nuclear localization.</p><p>Deletion of 17 C-terminal residues was based on 2D NMR of NSs-ΔN showing the presence of an intrinsically unfolded region. Notably, this truncation matches one reported in a study where RVFV NSs lacking these C-terminal residues (encoded by recombinant Semliki Forest virus) was localized in nuclei of infected cells, but did not form filaments (<xref ref-type="bibr" rid="bib59">Yadani et al., 1999</xref>). A more recent study suggests the 261-FVEV-264 motif is the binding site for the TFIIH subunit p62, and this interaction is required for filament formation (<xref ref-type="bibr" rid="bib14">Cyr et al., 2015</xref>). While the C-terminal tail (including the FVEV motif) is missing in the NSs-ΔNΔC construct, we nevertheless observed intranuclear filaments indistinguishable from filaments in rMP12-infected cells. Therefore, neither the intrinsically disordered C-terminal nor the N-terminal regions of NSs are required for filament formation.</p><p>The discrepancies between published results and our findings regarding the terminal regions of NSs may be reconciled if a role for the N-terminal domain of NSs in self-association is considered. The N-terminal domain is included in the NSs constructs used in both studies cited above (<xref ref-type="bibr" rid="bib14">Cyr et al., 2015</xref>; <xref ref-type="bibr" rid="bib59">Yadani et al., 1999</xref>) that suggest a critical role of the C-terminal tail for NSs self-association. However, removal of the N-terminal domain had a clear effect on the oligomeric state of NSs-ΔN, where the C-terminal tail is present (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). In crystal fibrils, NSs-ΔNΔC N- and C-termini are close to an apparent cleft in the middle of tetramer T1, which could accommodate the N-terminal domain, assuming full-length NSs fibrils contain the same core-domain arrangement. In which case, intermolecular interactions between monomer terminal regions are likely (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>). Arguably, deletion of either N- or C-terminal regions results in non-native interactions that destabilize fibrils, artifacts abrogated in a doubly truncated construct.</p><p>Our data have implications for understanding the interaction between NSs and TFIIH. The model for NSs function previously proposed (<xref ref-type="bibr" rid="bib14">Cyr et al., 2015</xref>) assumes initial binding of NSs to p62, with subsequent disintegration of the TFIIH complex, followed by sequestration of p44 into NSs filaments (<xref ref-type="bibr" rid="bib34">Le May et al., 2004</xref>). This hypothesis is not supported by our findings, as NSs-ΔNΔC lacks the putative p62-binding motif and still yields filaments. The apparent similarity in size and shape of NSs-ΔNΔC filaments to full-length NSs does not allow conclusions about their composition. We cannot rule out the possibility that NSs-ΔNΔC filaments observed in vivo are lacking other proteins such as p44 possibly associated with full-length NSs filaments.</p><p>The NSs core domain structure reported here represents a novel fold. Comparison of the secondary structure distribution in NSs-ΔNΔC and secondary structure predictions for other phleboviral NSs proteins shows very good agreement, suggesting that, despite low to moderate sequence identity of this core region (15–32%), all phleboviral NSs proteins share a similar core domain fold (<xref ref-type="fig" rid="fig8">Figure 8</xref>). They do however vary greatly in their N- and C-terminal regions, which is particularly evident when comparing NSs from viruses transmitted by mosquitos and sandflies (e.g. RVFV, sandfly fever viruses) with viruses transmitted by ticks (e.g. Heartland phlebovirus and SFTS phlebovirus) (<xref ref-type="fig" rid="fig8">Figure 8</xref>).</p><fig id="fig8" position="float"><object-id pub-id-type="doi">10.7554/eLife.29236.020</object-id><label>Figure 8.</label><caption><title>Sequence alignment of NSs proteins from human-pathogenic phleboviruses (SFTS, severe fever with thrombocytopenia syndrome virus).</title><p>Secondary structure elements for RVFV-NSs are shown on top of the alignment panels. For the N-terminal domain (top panel) these are based on secondary structure prediction by JPred4 (<xref ref-type="bibr" rid="bib17">Drozdetskiy et al., 2015</xref>) (dashed lines). Sequence similarity is indicated by gray shading for residues conserved or similar in at least 80% of sequences. Regions displayed in gray font are not aligned. Secondary structure predictions are also shown below each panel for Toscana virus and SFTS virus NSs.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-29236-fig8-v1"/></fig><p>The finding of highly organized fibrils in the NSs-ΔNΔC crystal lattice is intriguing due to the natural propensity of NSs for fibrillation in nuclei of RVFV-infected cells. Mutagenic analyses of interfaces defining the two types of crystal fibrils suggested that F1 likely represents the core architecture of NSs filaments, while F2 is a crystal packing artifact. T1 and T3 interface NSs variants were both detected in nuclei of infected cells. In immunofluorescence staining the muT3 interface variant appeared to be much more abundant than the muT1 variant, suggesting that the muT3 variant of NSs may be more stable than the muT1 interface mutant. This agrees with the predicted stability of the T1 tetramer (<xref ref-type="table" rid="table2">Table 2</xref>), making it less prone to degradation. To our knowledge, no other <italic>Phlebovirus</italic> causes intranuclear filament formation, and none of the residues stabilizing interfaces among NSs-ΔNΔC crystal fibrils is conserved in NSs sequences of phleboviruses other than RVFV.</p><p>Biological relevance of the F1 fibril is also supported by accessibility of the α8 helix in this assembly (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3</xref>), which is partially buried in the F2-specific T1-T2 interface (<xref ref-type="fig" rid="fig4">Figure 4</xref>). This helix harbors a binding site for SAP30, a component of a repressor complex that regulates transcription of the interferon-β promoter (<xref ref-type="bibr" rid="bib35">Le May et al., 2008</xref>). NSs arranged in the manner observed in NSs-ΔNΔC crystals would be able to bind to SAP30 and modulate SAP30 function.</p><p>PISA interface analysis indicates that potentially some NSs-ΔNΔC oligomers, but neither F1 nor F2 fibrils would be stable in solution. This agrees with the observation that NSs is distributed throughout the cytoplasm at early time points in cell infection experiments, and only forms distinct filaments inside nuclei. Fibrillation therefore depends on factors present in the nucleus, but not the cytosol. Essential factors could be binding partners, but also other conditions that shift the association equilibrium of NSs towards fibrils such as the excluded volume effect, or molecular crowding, which plays a role in compartmentalization and architecture of cell nuclei (<xref ref-type="bibr" rid="bib25">Hancock, 2004</xref>; <xref ref-type="bibr" rid="bib48">Richter et al., 2008</xref>). It is tempting to speculate that intranuclear crowding conditions are mimicked in crystallization where an excluded volume effect is induced by the precipitant polyethylene glycol (PEG).</p><p>RVFV is one of the most dangerous human pathogens with the potential to cause wide epidemics in the near future. The first high-resolution structure for the main RVFV virulence factor NSs and other data presented here will facilitate a deeper understanding of NSs function. Ongoing research will help determine if NSs filament assembly is required for virulence, a question that this study does not attempt to answer. NSs proteins of phleboviruses and other members of the <italic>Bunyavirales</italic> order are highly diverse in sequence, but all play roles in suppressing the innate immune response through various mechanisms (<xref ref-type="bibr" rid="bib40">Ly and Ikegami, 2016</xref>). In infected cells, NSs proteins are located in the nuclei and cytosol, or the cytosol only. Currently no other NSs protein is known to cause filaments characteristic for RVFV. To establish whether this unique property of RVFV NSs is related to virulence may require animal models, since NSs is dispensable for viral replication and in vitro cell infection, but is required to cause pathology (<xref ref-type="bibr" rid="bib10">Bouloy et al., 2001</xref>). The structure-based insights presented here should facilitate such studies. Development of modulators of fibril formation may be an attractive option for new therapeutics, especially given the conservation of interface residues in RVFV isolates.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Protein expression and purification</title><p>Expression constructs were prepared by cloning RVFV strain MP12 cDNA comprising full-length (residues 1–265), ΔN (residues 83–265), and ΔNΔC (residues 83–248) regions of NSs into a modified pMal-C2x vector (New England Biolabs, MA, USA) containing an N-terminal hexahistidine tag downstream of the <italic>malE</italic> (MBP) gene and a tobacco etch virus (TEV) protease sequence. Proteins were expressed using <italic>Escherichia coli</italic> BL21 (DE3). Cells were grown at 37°C in Luria-Bertani broth to an OD<sub>600</sub> of 0.6. Protein expression was induced with a final concentration of 0.5 mM isopropyl β-d-1-thiogalactopyranoside and allowed to proceed overnight at 18°C. Cells were pelleted by centrifugation and lysed in the presence of 10 mM phosphate buffer, 300 mM NaCl, 20 mM imidazole, pH 7.2 using sonication. Soluble proteins were separated from cell debris by centrifugation. Soluble protein was purified by nickel metal-affinity chromatography (IMAC). After binding, resin was washed extensively with 10 mM phosphate buffer, 2 M NaCl, 20 mM imidazole, pH 7.2 in order to dissociate any bound DNA. MBP-NSs was eluted in 10 mM phosphate buffer, 300 mM NaCl, 250 mM imidazole, pH 7.2, and dialyzed overnight at 4°C in 10 mM phosphate buffer, 300 mM NaCl, 2 mM DTT, pH 7.2 with simultaneous cleavage by TEV protease. MBP was separated from NSs by reverse nickel IMAC. NSs was further purified by size exclusion chromatography on a 16/60 S75 Superdex column (GE Healthcare, UK) in 10 mM phosphate, 300 mM NaCl, 1 mM DTT, pH 7.2.</p><p>Interface mutation variants of NSs-ΔNΔC were generated through site-directed mutagenesis. NSs-ΔNΔC-muT1 (Arg88Asp, Ser228Ala) was generated in two stages of amplification, while NSs-ΔNΔC-muT3 (Lys150Gly, Thr152Gly) and NSs-ΔNΔC-muT4 (Ile216Asp, Met219Ala) were made in single steps. Interface mutation variants were expressed and purified as previously described for wild-type NSs-ΔNΔC.</p></sec><sec id="s4-2"><title>Crystallization and structure determination</title><p>NSs 83–248 (NSs-ΔNΔC) was dialyzed into 20 mM HEPES, 150 mM NaCl, 1 mM DTT, pH 7.2, concentrated to 30 mg mL<sup>−1</sup>. Protein crystals were grown at 4°C by sitting-drop vapor diffusion in 0.1 M Tris-HCl pH 8.5, 8% (w/v) PEG 10,000 with protein and reservoir combined in a 2:1 ratio. Crystals of NSs-ΔNΔC grew as elongated hexagons and reached their maximum size of about 0.3 × 0.1 × 0.1 mm after two weeks. Crystals were cryo-protected by brief immersion in reservoir supplemented with 30% (v/v) glycerol then flash frozen in liquid nitrogen. Native and anomalous data were collected using a 2.0 Å wavelength beam at the Diamond Light Source (I03 beamline). Diffraction over a 500° angle yielded a high-multiplicity dataset with maximum resolution of 2.2 Å. Crystals indexed in space group <italic>P</italic>6<sub>4</sub>22 with cell dimensions a = 123.8 Å, b = 123.8 Å, c = 174 Å; α = 90°, β = 90°, γ = 120°. Data were indexed and integrated using XDS, scaled using XSCALE (<xref ref-type="bibr" rid="bib58">Kabsch, 2010</xref>), and merged with Scala (<xref ref-type="bibr" rid="bib21">Evans, 2006</xref>). The structure was solved by single anomalous dispersion (SAD); phase determination from native sulfur anomalous signal was performed using SHELX (<xref ref-type="bibr" rid="bib50">Sheldrick, 2010</xref>). PHENIX (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_014224">SCR_014224</ext-link>) AutoBuild was used for initial automated model-building (<xref ref-type="bibr" rid="bib54">Terwilliger et al., 2008</xref>). Density modification and model refinement was performed with REFMAC5 (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_014225">SCR_014225</ext-link>) (<xref ref-type="bibr" rid="bib43">Murshudov et al., 1997</xref>) and Coot (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_014222">SCR_014222</ext-link>) (<xref ref-type="bibr" rid="bib20">Emsley et al., 2010</xref>). Structure validation was conducted with the MolProbity (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_014226">SCR_014226</ext-link>) server (<xref ref-type="bibr" rid="bib12">Chen et al., 2010</xref>). Data collection and refinement statistics are listed in <xref ref-type="table" rid="table1">Table 1</xref>.</p></sec><sec id="s4-3"><title>NMR spectroscopy</title><p>NSs constructs were isotopically labeled by expression in M9 minimal media, supplemented with 1 g L<sup>−1</sup> of <sup>15</sup>NH<sub>4</sub>Cl and purified as described above for native proteins. NMR samples typically contained 0.3 mM protein in 10 mM phosphate, 50 mM NaCl, 0.25 mM DTT, pH 7.2, 5% (v/v) D<sub>2</sub>O. <sup>1</sup>H-<sup>15</sup>N HSQC spectra were recorded on a Bruker DRX500 spectrometer equipped with a 5 mm TXIz probe at 15°C. Spectra were processed with NMRPipe (<xref ref-type="bibr" rid="bib15">Delaglio et al., 1995</xref>) and analyzed with CCPN Analysis 2 (<xref ref-type="bibr" rid="bib56">Vranken et al., 2005</xref>). For interface mutation variants of NSs-ΔNΔC, samples contained 0.03–0.25 mM protein in 10 mM phosphate, 150 mM NaF, 1 mM DTT, pH 7.2, 5% (v/v) D<sub>2</sub>O. One-dimensional <sup>1</sup>H spectra were recorded with a spectral resolution of 1.7 Hz on a Bruker Ascend 700 MHz spectrometer equipped with a Prodigy TCI probe at 22°C. The spectra were processed and analyzed using Bruker Topspin 3 (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_014227">SCR_014227</ext-link>).</p></sec><sec id="s4-4"><title>Cells and viruses</title><p>Vero-E6 cells (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/CVCL_0574">CVCL_0574</ext-link>) were purchased from the European Collection of Authenticated Cell Cultures (ECACC), and tested negative for mycoplasma. Cells were grown in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% (v/v) fetal calf serum. Cell lines were grown at 37°C with 5% CO<sub>2</sub> unless otherwise stated. Recombinant viruses containing truncated or mutated NSs proteins were generated using reverse genetics as previously described (<xref ref-type="bibr" rid="bib11">Brennan et al., 2014</xref>; <xref ref-type="bibr" rid="bib35">Le May et al., 2008</xref>). Stocks of recombinant viruses were grown in BHK-21 cells at 33°C by infecting at a multiplicity of infection (MOI) of 0.01 and harvesting the culture medium at 5–7 days post infection (p.i.) All experiments with infectious virus were conducted under containment level 3 conditions. RT-PCR analysis of p1 stock viruses was performed to confirm the correct configuration of the recombinant virus S RNA.</p></sec><sec id="s4-5"><title>Virus titration by plaque assay</title><p>BHK-21 (clone 13) cells (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/CVCL_1915">CVCL_1915</ext-link>) were purchased from the European Collection of Authenticated Cell Cultures (ECACC), and tested negative for mycoplasma. Cells were infected with serial dilutions of virus and incubated under an overlay consisting of Glasgow minimum essential medium (GMEM) supplemented with 2% (v/v) newborn calf serum and 0.6% Avicel (w/v) (FMC BioPolymer, Philadelphia, PA) at 37°C for 4 days. Cell monolayers were fixed with 4% (w/v) formaldehyde and plaques were visualized by Giemsa staining.</p></sec><sec id="s4-6"><title>Immunofluorescence microscopy of infected cells</title><p>Vero-E6 cells were grown on glass coverslips (13 mm diameter), infected with recombinant or parental RVFV at an MOI of 5 and fixed at 24 h p.i. in 4% (w/v) formaldehyde in PBS. After permeabilization with 0.1% (v/v) Triton X-100 in PBS, cells were stained with specific primary antibodies, followed by secondary antibody conjugates. Localization of the fluorescently labeled proteins was examined using a Zeiss LSM-710 confocal microscope. Images in <xref ref-type="fig" rid="fig6">Figures 6</xref> and <xref ref-type="fig" rid="fig7">7</xref> are representatives of two independent infection experiments, with two repeats for each antibody.</p></sec><sec id="s4-7"><title>Thin-section electron microscopy</title><p>Monolayer cultures of Vero-E6 cells were seeded in 6-well plates and infected with RVFV MP12 for 24 h p.i. at an MOI of 3, and subsequently fixed with 2.5% (v/v) glutaraldehyde overnight at 4°C. Cells were scraped and pelleted by centrifugation followed by fixation with 1% (w/v) osmium tetroxide (TAAB Labs, UK) and staining with 2% (w/v) aqueous uranyl acetate for 1 hr at room temperature. Cells were then harvested into PBS and pelleted through 1% (w/v) SeaPlaque agarose (Sigma, UK) at 45°C. The agar was set at 4°C and cell pellets were cut into ~1 mm cubes, which were dehydrated through a graded alcohol series (30–100% (v/v)) and embedded in Epon 812 resin (TAAB Labs, UK) followed by polymerization for 3 days at 65°C. Thin sections of 120 nm were cut with a UC6 ultramicrotome (Leica Microsystems, Germany) and examined with a JEOL 1200 EX II electron microscope and images were recorded on a Gatan Orius CCD camera.</p></sec><sec id="s4-8"><title>Accession code</title><p>The NSs-ΔNΔC protein structure, and the data used to derive these, have been deposited at PDBe (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_004312">SCR_004312</ext-link>) with accession number 5OOO.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We acknowledge the Diamond Light Source for access to Data Collection facilities.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Investigation, Visualization, Writing—original draft, Writing—review and editing</p></fn><fn fn-type="con" id="con2"><p>Resources, Investigation, Visualization, Writing—review and editing</p></fn><fn fn-type="con" id="con3"><p>Investigation, Writing—review and editing</p></fn><fn fn-type="con" id="con4"><p>Formal analysis, Investigation</p></fn><fn fn-type="con" id="con5"><p>Investigation, Visualization, Writing—review and editing</p></fn><fn fn-type="con" id="con6"><p>Resources, Supervision</p></fn><fn fn-type="con" id="con7"><p>Formal analysis, Methodology</p></fn><fn fn-type="con" id="con8"><p>Conceptualization, Supervision, Funding acquisition</p></fn><fn fn-type="con" id="con9"><p>Conceptualization, Supervision, Funding acquisition, Investigation, Writing—original draft, Project administration, Writing—review and editing</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><object-id pub-id-type="doi">10.7554/eLife.29236.021</object-id><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-29236-transrepform-v1.docx"/></supplementary-material><sec id="s7" sec-type="datasets"><title>Major datasets</title><p>The following dataset was generated:</p><p><related-object content-type="generated-dataset" id="dataset1" source-id="http://www.rcsb.org/pdb/explore/explore.do?structureId=5OOO" source-id-type="uri"><collab collab-type="author">Barski M</collab><collab collab-type="author">Potter J</collab><collab collab-type="author">Schwarz-Linek U</collab><year>2017</year><source>Structure of the Rift Valley fever virus NSs protein core domain</source><ext-link ext-link-type="uri" xlink:href="http://www.rcsb.org/pdb/explore/explore.do?structureId=5OOO">http://www.rcsb.org/pdb/explore/explore.do?structureId=5OOO</ext-link><comment>Publicly available at the RCSB Protein Data Bank (accession no:5OOO)</comment></related-object></p></sec></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname> <given-names>MJ</given-names></name><name><surname>Lefkowitz</surname> <given-names>EJ</given-names></name><name><surname>King</surname> <given-names>AMQ</given-names></name><name><surname>Harrach</surname> <given-names>B</given-names></name><name><surname>Harrison</surname> <given-names>RL</given-names></name><name><surname>Knowles</surname> <given-names>NJ</given-names></name><name><surname>Kropinski</surname> <given-names>AM</given-names></name><name><surname>Krupovic</surname> <given-names>M</given-names></name><name><surname>Kuhn</surname> <given-names>JH</given-names></name><name><surname>Mushegian</surname> <given-names>AR</given-names></name><name><surname>Nibert</surname> <given-names>M</given-names></name><name><surname>Sabanadzovic</surname> <given-names>S</given-names></name><name><surname>Sanfaçon</surname> <given-names>H</given-names></name><name><surname>Siddell</surname> <given-names>SG</given-names></name><name><surname>Simmonds</surname> <given-names>P</given-names></name><name><surname>Varsani</surname> <given-names>A</given-names></name><name><surname>Zerbini</surname> <given-names>FM</given-names></name><name><surname>Gorbalenya</surname> <given-names>AE</given-names></name><name><surname>Davison</surname> <given-names>AJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Changes to taxonomy and the international code of virus classification and nomenclature ratified by the international committee on taxonomy of viruses (2017)</article-title><source>Archives of Virology</source><volume>162</volume><fpage>2505</fpage><lpage>2538</lpage><pub-id pub-id-type="doi">10.1007/s00705-017-3358-5</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baer</surname> <given-names>A</given-names></name><name><surname>Austin</surname> <given-names>D</given-names></name><name><surname>Narayanan</surname> <given-names>A</given-names></name><name><surname>Popova</surname> <given-names>T</given-names></name><name><surname>Kainulainen</surname> <given-names>M</given-names></name><name><surname>Bailey</surname> <given-names>C</given-names></name><name><surname>Kashanchi</surname> <given-names>F</given-names></name><name><surname>Weber</surname> <given-names>F</given-names></name><name><surname>Kehn-Hall</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Induction of DNA damage signaling upon rift valley fever virus infection results in cell cycle arrest and increased viral replication</article-title><source>Journal of Biological Chemistry</source><volume>287</volume><fpage>7399</fpage><lpage>7410</lpage><pub-id pub-id-type="doi">10.1074/jbc.M111.296608</pub-id><pub-id pub-id-type="pmid">22223653</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balkhy</surname> <given-names>HH</given-names></name><name><surname>Memish</surname> <given-names>ZA</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Rift Valley fever: an uninvited zoonosis in the arabian peninsula</article-title><source>International Journal of Antimicrobial Agents</source><volume>21</volume><fpage>153</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1016/S0924-8579(02)00295-9</pub-id><pub-id pub-id-type="pmid">12615379</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Billecocq</surname> <given-names>A</given-names></name><name><surname>Spiegel</surname> <given-names>M</given-names></name><name><surname>Vialat</surname> <given-names>P</given-names></name><name><surname>Kohl</surname> <given-names>A</given-names></name><name><surname>Weber</surname> <given-names>F</given-names></name><name><surname>Bouloy</surname> <given-names>M</given-names></name><name><surname>Haller</surname> <given-names>O</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>NSs protein of rift valley fever virus blocks interferon production by inhibiting host gene transcription</article-title><source>Journal of Virology</source><volume>78</volume><fpage>9798</fpage><lpage>9806</lpage><pub-id pub-id-type="doi">10.1128/JVI.78.18.9798-9806.2004</pub-id><pub-id pub-id-type="pmid">15331713</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Billecocq</surname> <given-names>A</given-names></name><name><surname>Gauliard</surname> <given-names>N</given-names></name><name><surname>Le May</surname> <given-names>N</given-names></name><name><surname>Elliott</surname> <given-names>RM</given-names></name><name><surname>Flick</surname> <given-names>R</given-names></name><name><surname>Bouloy</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>RNA polymerase I-mediated expression of viral RNA for the rescue of infectious virulent and avirulent Rift Valley fever viruses</article-title><source>Virology</source><volume>378</volume><fpage>377</fpage><lpage>384</lpage><pub-id pub-id-type="doi">10.1016/j.virol.2008.05.033</pub-id><pub-id pub-id-type="pmid">18614193</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bird</surname> <given-names>BH</given-names></name><name><surname>Albariño</surname> <given-names>CG</given-names></name><name><surname>Hartman</surname> <given-names>AL</given-names></name><name><surname>Erickson</surname> <given-names>BR</given-names></name><name><surname>Ksiazek</surname> <given-names>TG</given-names></name><name><surname>Nichol</surname> <given-names>ST</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Rift valley fever virus lacking the NSs and NSm genes is highly attenuated, confers protective immunity from virulent virus challenge, and allows for differential identification of infected and vaccinated animals</article-title><source>Journal of Virology</source><volume>82</volume><fpage>2681</fpage><lpage>2691</lpage><pub-id pub-id-type="doi">10.1128/JVI.02501-07</pub-id><pub-id pub-id-type="pmid">18199647</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bird</surname> <given-names>BH</given-names></name><name><surname>Maartens</surname> <given-names>LH</given-names></name><name><surname>Campbell</surname> <given-names>S</given-names></name><name><surname>Erasmus</surname> <given-names>BJ</given-names></name><name><surname>Erickson</surname> <given-names>BR</given-names></name><name><surname>Dodd</surname> <given-names>KA</given-names></name><name><surname>Spiropoulou</surname> <given-names>CF</given-names></name><name><surname>Cannon</surname> <given-names>D</given-names></name><name><surname>Drew</surname> <given-names>CP</given-names></name><name><surname>Knust</surname> <given-names>B</given-names></name><name><surname>McElroy</surname> <given-names>AK</given-names></name><name><surname>Khristova</surname> <given-names>ML</given-names></name><name><surname>Albariño</surname> <given-names>CG</given-names></name><name><surname>Nichol</surname> <given-names>ST</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Rift valley fever virus vaccine lacking the NSs and NSm genes is safe, nonteratogenic, and confers protection from viremia, pyrexia, and abortion following challenge in adult and pregnant sheep</article-title><source>Journal of Virology</source><volume>85</volume><fpage>12901</fpage><lpage>12909</lpage><pub-id pub-id-type="doi">10.1128/JVI.06046-11</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bornholdt</surname> <given-names>ZA</given-names></name><name><surname>Prasad</surname> <given-names>BV</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>X-ray structure of NS1 from a highly pathogenic H5N1 influenza virus</article-title><source>Nature</source><volume>456</volume><fpage>985</fpage><lpage>988</lpage><pub-id pub-id-type="doi">10.1038/nature07444</pub-id><pub-id pub-id-type="pmid">18987632</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boshra</surname> <given-names>H</given-names></name><name><surname>Lorenzo</surname> <given-names>G</given-names></name><name><surname>Busquets</surname> <given-names>N</given-names></name><name><surname>Brun</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Rift valley fever: recent insights into pathogenesis and prevention</article-title><source>Journal of Virology</source><volume>85</volume><fpage>6098</fpage><lpage>6105</lpage><pub-id pub-id-type="doi">10.1128/JVI.02641-10</pub-id><pub-id pub-id-type="pmid">21450816</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bouloy</surname> <given-names>M</given-names></name><name><surname>Janzen</surname> <given-names>C</given-names></name><name><surname>Vialat</surname> <given-names>P</given-names></name><name><surname>Khun</surname> <given-names>H</given-names></name><name><surname>Pavlovic</surname> <given-names>J</given-names></name><name><surname>Huerre</surname> <given-names>M</given-names></name><name><surname>Haller</surname> <given-names>O</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs</article-title><source>Journal of Virology</source><volume>75</volume><fpage>1371</fpage><lpage>1377</lpage><pub-id pub-id-type="doi">10.1128/JVI.75.3.1371-1377.2001</pub-id><pub-id pub-id-type="pmid">11152510</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brennan</surname> <given-names>B</given-names></name><name><surname>Welch</surname> <given-names>SR</given-names></name><name><surname>Elliott</surname> <given-names>RM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The consequences of reconfiguring the ambisense S genome segment of Rift Valley fever virus on viral replication in mammalian and mosquito cells and for genome packaging</article-title><source>PLoS Pathogens</source><volume>10</volume><elocation-id>e1003922</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1003922</pub-id><pub-id pub-id-type="pmid">24550727</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>VB</given-names></name><name><surname>Arendall</surname> <given-names>WB</given-names></name><name><surname>Headd</surname> <given-names>JJ</given-names></name><name><surname>Keedy</surname> <given-names>DA</given-names></name><name><surname>Immormino</surname> <given-names>RM</given-names></name><name><surname>Kapral</surname> <given-names>GJ</given-names></name><name><surname>Murray</surname> <given-names>LW</given-names></name><name><surname>Richardson</surname> <given-names>JS</given-names></name><name><surname>Richardson</surname> <given-names>DC</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>MolProbity: all-atom structure validation for macromolecular crystallography</article-title><source>Acta Crystallographica Section D Biological Crystallography</source><volume>66</volume><fpage>12</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1107/S0907444909042073</pub-id><pub-id pub-id-type="pmid">20057044</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chevalier</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Relevance of rift valley fever to public health in the european union</article-title><source>Clinical Microbiology and Infection</source><volume>19</volume><fpage>705</fpage><lpage>708</lpage><pub-id pub-id-type="doi">10.1111/1469-0691.12163</pub-id><pub-id pub-id-type="pmid">23517372</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cyr</surname> <given-names>N</given-names></name><name><surname>de la Fuente</surname> <given-names>C</given-names></name><name><surname>Lecoq</surname> <given-names>L</given-names></name><name><surname>Guendel</surname> <given-names>I</given-names></name><name><surname>Chabot</surname> <given-names>PR</given-names></name><name><surname>Kehn-Hall</surname> <given-names>K</given-names></name><name><surname>Omichinski</surname> <given-names>JG</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>A ΩXaV motif in the Rift Valley fever virus NSs protein is essential for degrading p62, forming nuclear filaments and virulence</article-title><source>PNAS</source><volume>112</volume><fpage>6021</fpage><lpage>6026</lpage><pub-id pub-id-type="doi">10.1073/pnas.1503688112</pub-id><pub-id pub-id-type="pmid">25918396</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delaglio</surname> <given-names>F</given-names></name><name><surname>Grzesiek</surname> <given-names>S</given-names></name><name><surname>Vuister</surname> <given-names>GW</given-names></name><name><surname>Zhu</surname> <given-names>G</given-names></name><name><surname>Pfeifer</surname> <given-names>J</given-names></name><name><surname>Bax</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>NMRPipe: a multidimensional spectral processing system based on UNIX pipes</article-title><source>Journal of Biomolecular NMR</source><volume>6</volume><fpage>277</fpage><lpage>293</lpage><pub-id pub-id-type="doi">10.1007/BF00197809</pub-id><pub-id pub-id-type="pmid">8520220</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dessau</surname> <given-names>M</given-names></name><name><surname>Modis</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Crystal structure of glycoprotein C from rift valley fever virus</article-title><source>PNAS</source><volume>110</volume><fpage>1696</fpage><lpage>1701</lpage><pub-id pub-id-type="doi">10.1073/pnas.1217780110</pub-id><pub-id pub-id-type="pmid">23319635</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drozdetskiy</surname> <given-names>A</given-names></name><name><surname>Cole</surname> <given-names>C</given-names></name><name><surname>Procter</surname> <given-names>J</given-names></name><name><surname>Barton</surname> <given-names>GJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>JPred4: a protein secondary structure prediction server</article-title><source>Nucleic Acids Research</source><volume>43</volume><fpage>W389</fpage><lpage>W394</lpage><pub-id pub-id-type="doi">10.1093/nar/gkv332</pub-id><pub-id pub-id-type="pmid">25883141</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elliott</surname> <given-names>RM</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Bunyaviruses and climate change</article-title><source>Clinical Microbiology and Infection</source><volume>15</volume><fpage>510</fpage><lpage>517</lpage><pub-id pub-id-type="doi">10.1111/j.1469-0691.2009.02849.x</pub-id><pub-id pub-id-type="pmid">19604275</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elliott</surname> <given-names>RM</given-names></name><name><surname>Brennan</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Emerging phleboviruses</article-title><source>Current Opinion in Virology</source><volume>5</volume><fpage>50</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1016/j.coviro.2014.01.011</pub-id><pub-id pub-id-type="pmid">24607799</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emsley</surname> <given-names>P</given-names></name><name><surname>Lohkamp</surname> <given-names>B</given-names></name><name><surname>Scott</surname> <given-names>WG</given-names></name><name><surname>Cowtan</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Features and development of coot</article-title><source>Acta Crystallographica Section D Biological Crystallography</source><volume>66</volume><fpage>486</fpage><lpage>501</lpage><pub-id pub-id-type="doi">10.1107/S0907444910007493</pub-id><pub-id pub-id-type="pmid">20383002</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Scaling and assessment of data quality</article-title><source>Acta Crystallographica Section D Biological Crystallography</source><volume>62</volume><fpage>72</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1107/S0907444905036693</pub-id><pub-id pub-id-type="pmid">16369096</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferron</surname> <given-names>F</given-names></name><name><surname>Li</surname> <given-names>Z</given-names></name><name><surname>Danek</surname> <given-names>EI</given-names></name><name><surname>Luo</surname> <given-names>D</given-names></name><name><surname>Wong</surname> <given-names>Y</given-names></name><name><surname>Coutard</surname> <given-names>B</given-names></name><name><surname>Lantez</surname> <given-names>V</given-names></name><name><surname>Charrel</surname> <given-names>R</given-names></name><name><surname>Canard</surname> <given-names>B</given-names></name><name><surname>Walz</surname> <given-names>T</given-names></name><name><surname>Lescar</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The hexamer structure of rift valley fever virus nucleoprotein suggests a mechanism for its assembly into ribonucleoprotein complexes</article-title><source>PLoS Pathogens</source><volume>7</volume><fpage>e1002030</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1002030</pub-id><pub-id pub-id-type="pmid">21589902</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feuerstein</surname> <given-names>S</given-names></name><name><surname>Solyom</surname> <given-names>Z</given-names></name><name><surname>Aladag</surname> <given-names>A</given-names></name><name><surname>Favier</surname> <given-names>A</given-names></name><name><surname>Schwarten</surname> <given-names>M</given-names></name><name><surname>Hoffmann</surname> <given-names>S</given-names></name><name><surname>Willbold</surname> <given-names>D</given-names></name><name><surname>Brutscher</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Transient structure and SH3 interaction sites in an intrinsically disordered fragment of the hepatitis C virus protein NS5A</article-title><source>Journal of Molecular Biology</source><volume>420</volume><fpage>310</fpage><lpage>323</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2012.04.023</pub-id><pub-id pub-id-type="pmid">22543239</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Golnar</surname> <given-names>AJ</given-names></name><name><surname>Turell</surname> <given-names>MJ</given-names></name><name><surname>LaBeaud</surname> <given-names>AD</given-names></name><name><surname>Kading</surname> <given-names>RC</given-names></name><name><surname>Hamer</surname> <given-names>GL</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Predicting the mosquito species and vertebrate species involved in the theoretical transmission of rift valley fever virus in the United States</article-title><source>PLoS Neglected Tropical Diseases</source><volume>8</volume><fpage>e3163</fpage><pub-id pub-id-type="doi">10.1371/journal.pntd.0003163</pub-id><pub-id pub-id-type="pmid">25211133</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hancock</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Internal organisation of the nucleus: assembly of compartments by macromolecular crowding and the nuclear matrix model</article-title><source>Biology of the Cell</source><volume>96</volume><fpage>595</fpage><lpage>601</lpage><pub-id pub-id-type="doi">10.1016/j.biolcel.2004.05.003</pub-id><pub-id pub-id-type="pmid">15519694</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holm</surname> <given-names>L</given-names></name><name><surname>Rosenström</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Dali server: conservation mapping in 3D</article-title><source>Nucleic Acids Research</source><volume>38</volume><fpage>W545</fpage><lpage>W549</lpage><pub-id pub-id-type="doi">10.1093/nar/gkq366</pub-id><pub-id pub-id-type="pmid">20457744</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikegami</surname> <given-names>T</given-names></name><name><surname>Narayanan</surname> <given-names>K</given-names></name><name><surname>Won</surname> <given-names>S</given-names></name><name><surname>Kamitani</surname> <given-names>W</given-names></name><name><surname>Peters</surname> <given-names>CJ</given-names></name><name><surname>Makino</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2009">2009a</year><article-title>Dual functions of Rift Valley fever virus NSs protein: inhibition of host mRNA transcription and post-transcriptional downregulation of protein kinase PKR</article-title><source>Annals of the New York Academy of Sciences</source><volume>1171 Suppl 1</volume><fpage>E75</fpage><lpage>E85</lpage><pub-id pub-id-type="doi">10.1111/j.1749-6632.2009.05054.x</pub-id><pub-id pub-id-type="pmid">19751406</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikegami</surname> <given-names>T</given-names></name><name><surname>Narayanan</surname> <given-names>K</given-names></name><name><surname>Won</surname> <given-names>S</given-names></name><name><surname>Kamitani</surname> <given-names>W</given-names></name><name><surname>Peters</surname> <given-names>CJ</given-names></name><name><surname>Makino</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2009">2009b</year><article-title>Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation</article-title><source>PLoS Pathogens</source><volume>5</volume><fpage>e1000287</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1000287</pub-id><pub-id pub-id-type="pmid">19197350</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikegami</surname> <given-names>T</given-names></name><name><surname>Makino</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The pathogenesis of rift valley fever</article-title><source>Viruses</source><volume>3</volume><fpage>493</fpage><lpage>519</lpage><pub-id pub-id-type="doi">10.3390/v3050493</pub-id><pub-id pub-id-type="pmid">21666766</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kainulainen</surname> <given-names>M</given-names></name><name><surname>Habjan</surname> <given-names>M</given-names></name><name><surname>Hubel</surname> <given-names>P</given-names></name><name><surname>Busch</surname> <given-names>L</given-names></name><name><surname>Lau</surname> <given-names>S</given-names></name><name><surname>Colinge</surname> <given-names>J</given-names></name><name><surname>Superti-Furga</surname> <given-names>G</given-names></name><name><surname>Pichlmair</surname> <given-names>A</given-names></name><name><surname>Weber</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Virulence factor NSs of rift valley fever virus recruits the F-box protein FBXO3 to degrade subunit p62 of general transcription factor TFIIH</article-title><source>Journal of Virology</source><volume>88</volume><fpage>3464</fpage><lpage>3473</lpage><pub-id pub-id-type="doi">10.1128/JVI.02914-13</pub-id><pub-id pub-id-type="pmid">24403578</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalveram</surname> <given-names>B</given-names></name><name><surname>Lihoradova</surname> <given-names>O</given-names></name><name><surname>Ikegami</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>NSs protein of rift valley fever virus promotes posttranslational downregulation of the TFIIH subunit p62</article-title><source>Journal of Virology</source><volume>85</volume><fpage>6234</fpage><lpage>6243</lpage><pub-id pub-id-type="doi">10.1128/JVI.02255-10</pub-id><pub-id pub-id-type="pmid">21543505</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krissinel</surname> <given-names>E</given-names></name><name><surname>Henrick</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions</article-title><source>Acta Crystallographica Section D Biological Crystallography</source><volume>60</volume><fpage>2256</fpage><lpage>2268</lpage><pub-id pub-id-type="doi">10.1107/S0907444904026460</pub-id><pub-id pub-id-type="pmid">15572779</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krissinel</surname> <given-names>E</given-names></name><name><surname>Henrick</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Inference of macromolecular assemblies from crystalline state</article-title><source>Journal of Molecular Biology</source><volume>372</volume><fpage>774</fpage><lpage>797</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2007.05.022</pub-id><pub-id pub-id-type="pmid">17681537</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le May</surname> <given-names>N</given-names></name><name><surname>Dubaele</surname> <given-names>S</given-names></name><name><surname>Proietti De Santis</surname> <given-names>L</given-names></name><name><surname>Billecocq</surname> <given-names>A</given-names></name><name><surname>Bouloy</surname> <given-names>M</given-names></name><name><surname>Egly</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus</article-title><source>Cell</source><volume>116</volume><fpage>541</fpage><lpage>550</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(04)00132-1</pub-id><pub-id pub-id-type="pmid">14980221</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le May</surname> <given-names>N</given-names></name><name><surname>Mansuroglu</surname> <given-names>Z</given-names></name><name><surname>Léger</surname> <given-names>P</given-names></name><name><surname>Josse</surname> <given-names>T</given-names></name><name><surname>Blot</surname> <given-names>G</given-names></name><name><surname>Billecocq</surname> <given-names>A</given-names></name><name><surname>Flick</surname> <given-names>R</given-names></name><name><surname>Jacob</surname> <given-names>Y</given-names></name><name><surname>Bonnefoy</surname> <given-names>E</given-names></name><name><surname>Bouloy</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>A SAP30 complex inhibits IFN-beta expression in rift valley fever virus infected cells</article-title><source>PLoS Pathogens</source><volume>4</volume><elocation-id>e13</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.0040013</pub-id><pub-id pub-id-type="pmid">18225953</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leung</surname> <given-names>DW</given-names></name><name><surname>Ginder</surname> <given-names>ND</given-names></name><name><surname>Fulton</surname> <given-names>DB</given-names></name><name><surname>Nix</surname> <given-names>J</given-names></name><name><surname>Basler</surname> <given-names>CF</given-names></name><name><surname>Honzatko</surname> <given-names>RB</given-names></name><name><surname>Amarasinghe</surname> <given-names>GK</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Structure of the Ebola VP35 interferon inhibitory domain</article-title><source>PNAS</source><volume>106</volume><fpage>411</fpage><lpage>416</lpage><pub-id pub-id-type="doi">10.1073/pnas.0807854106</pub-id><pub-id pub-id-type="pmid">19122151</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lihoradova</surname> <given-names>O</given-names></name><name><surname>Ikegami</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Countermeasure development for Rift Valley fever: deletion, modification or targeting of major virulence factor NSs</article-title><source>Future Virology</source><volume>9</volume><fpage>27</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.2217/fvl.13.117</pub-id><pub-id pub-id-type="pmid">24910709</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>J</given-names></name><name><surname>Lynch</surname> <given-names>PA</given-names></name><name><surname>Chien</surname> <given-names>CY</given-names></name><name><surname>Montelione</surname> <given-names>GT</given-names></name><name><surname>Krug</surname> <given-names>RM</given-names></name><name><surname>Berman</surname> <given-names>HM</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Crystal structure of the unique RNA-binding domain of the influenza virus NS1 protein</article-title><source>Nature Structural &amp; Molecular Biology</source><volume>4</volume><fpage>896</fpage><lpage>899</lpage><pub-id pub-id-type="doi">10.1038/nsb1197-896</pub-id><pub-id pub-id-type="pmid">9360602</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>Q</given-names></name><name><surname>Li</surname> <given-names>Z</given-names></name><name><surname>Li</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Use B-factor related features for accurate classification between protein binding interfaces and crystal packing contacts</article-title><source>BMC Bioinformatics</source><volume>15</volume><elocation-id>S3</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2105-15-S16-S3</pub-id><pub-id pub-id-type="pmid">25522196</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ly</surname> <given-names>HJ</given-names></name><name><surname>Ikegami</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Rift Valley fever virus NSs protein functions and the similarity to other bunyavirus NSs proteins</article-title><source>Virology journal</source><volume>13</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1186/s12985-016-0573-8</pub-id><pub-id pub-id-type="pmid">27368371</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mansuroglu</surname> <given-names>Z</given-names></name><name><surname>Josse</surname> <given-names>T</given-names></name><name><surname>Gilleron</surname> <given-names>J</given-names></name><name><surname>Billecocq</surname> <given-names>A</given-names></name><name><surname>Leger</surname> <given-names>P</given-names></name><name><surname>Bouloy</surname> <given-names>M</given-names></name><name><surname>Bonnefoy</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Nonstructural NSs protein of rift valley fever virus interacts with pericentromeric DNA sequences of the host cell, inducing chromosome cohesion and segregation defects</article-title><source>Journal of Virology</source><volume>84</volume><fpage>928</fpage><lpage>939</lpage><pub-id pub-id-type="doi">10.1128/JVI.01165-09</pub-id><pub-id pub-id-type="pmid">19889787</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muller</surname> <given-names>R</given-names></name><name><surname>Saluzzo</surname> <given-names>JF</given-names></name><name><surname>Lopez</surname> <given-names>N</given-names></name><name><surname>Dreier</surname> <given-names>T</given-names></name><name><surname>Turell</surname> <given-names>M</given-names></name><name><surname>Smith</surname> <given-names>J</given-names></name><name><surname>Bouloy</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment</article-title><source>The American Journal of Tropical Medicine and Hygiene</source><volume>53</volume><fpage>405</fpage><lpage>411</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.1995.53.405</pub-id><pub-id pub-id-type="pmid">7485695</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murshudov</surname> <given-names>GN</given-names></name><name><surname>Vagin</surname> <given-names>AA</given-names></name><name><surname>Dodson</surname> <given-names>EJ</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Refinement of macromolecular structures by the maximum-likelihood method</article-title><source>Acta Crystallographica Section D Biological Crystallography</source><volume>53</volume><fpage>240</fpage><lpage>255</lpage><pub-id pub-id-type="doi">10.1107/S0907444996012255</pub-id><pub-id pub-id-type="pmid">15299926</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pepin</surname> <given-names>M</given-names></name><name><surname>Bouloy</surname> <given-names>M</given-names></name><name><surname>Bird</surname> <given-names>BH</given-names></name><name><surname>Kemp</surname> <given-names>A</given-names></name><name><surname>Paweska</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Rift Valley fever virus(Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention</article-title><source>Veterinary Research</source><volume>41</volume><fpage>61</fpage><pub-id pub-id-type="doi">10.1051/vetres/2010033</pub-id><pub-id pub-id-type="pmid">21188836</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Plyusnin</surname> <given-names>A</given-names></name><name><surname>Beaty</surname> <given-names>BJ</given-names></name><name><surname>Elliott</surname> <given-names>RM</given-names></name><name><surname>Goldbach</surname> <given-names>R</given-names></name><name><surname>Kormelink</surname> <given-names>R</given-names></name><name><surname>Lundkvist</surname> <given-names>A</given-names></name><name><surname>Schmaljohn</surname> <given-names>CS</given-names></name><name><surname>Tesh</surname> <given-names>RB</given-names></name></person-group><year iso-8601-date="2012">2012</year><chapter-title>Bunyaviridae</chapter-title><source>Virus Taxonomy</source><fpage>725</fpage><lpage>741</lpage></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Randall</surname> <given-names>RE</given-names></name><name><surname>Goodbourn</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures</article-title><source>Journal of General Virology</source><volume>89</volume><fpage>1</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1099/vir.0.83391-0</pub-id><pub-id pub-id-type="pmid">18089727</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raymond</surname> <given-names>DD</given-names></name><name><surname>Piper</surname> <given-names>ME</given-names></name><name><surname>Gerrard</surname> <given-names>SR</given-names></name><name><surname>Smith</surname> <given-names>JL</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Structure of the rift valley fever virus nucleocapsid protein reveals another architecture for RNA encapsidation</article-title><source>PNAS</source><volume>107</volume><fpage>11769</fpage><lpage>11774</lpage><pub-id pub-id-type="doi">10.1073/pnas.1001760107</pub-id><pub-id pub-id-type="pmid">20547879</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richter</surname> <given-names>K</given-names></name><name><surname>Nessling</surname> <given-names>M</given-names></name><name><surname>Lichter</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Macromolecular crowding and its potential impact on nuclear function</article-title><source>Biochimica et Biophysica Acta (BBA) - Molecular Cell Research</source><volume>1783</volume><fpage>2100</fpage><lpage>2107</lpage><pub-id pub-id-type="doi">10.1016/j.bbamcr.2008.07.017</pub-id><pub-id pub-id-type="pmid">18723053</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rolin</surname> <given-names>AI</given-names></name><name><surname>Berrang-Ford</surname> <given-names>L</given-names></name><name><surname>Kulkarni</surname> <given-names>MA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The risk of Rift Valley fever virus introduction and establishment in the United States and European Union</article-title><source>Emerging Microbes &amp; Infections</source><volume>2</volume><fpage>e81</fpage><pub-id pub-id-type="doi">10.1038/emi.2013.81</pub-id><pub-id pub-id-type="pmid">26038446</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheldrick</surname> <given-names>GM</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Experimental phasing with SHELXC/D/E: combining chain tracing with density modification</article-title><source>Acta Crystallographica Section D Biological Crystallography</source><volume>66</volume><fpage>479</fpage><lpage>485</lpage><pub-id pub-id-type="doi">10.1107/S0907444909038360</pub-id><pub-id pub-id-type="pmid">20383001</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Struthers</surname> <given-names>JK</given-names></name><name><surname>Swanepoel</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="1982">1982</year><article-title>Identification of a major non-structural protein in the nuclei of Rift Valley fever virus-infected cells</article-title><source>Journal of General Virology</source><volume>60</volume><fpage>381</fpage><lpage>384</lpage><pub-id pub-id-type="doi">10.1099/0022-1317-60-2-381</pub-id><pub-id pub-id-type="pmid">7108491</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swanepoel</surname> <given-names>R</given-names></name><name><surname>Blackburn</surname> <given-names>NK</given-names></name></person-group><year iso-8601-date="1977">1977</year><article-title>Demonstration of nuclear immunofluorescence in rift valley fever infected cells</article-title><source>Journal of General Virology</source><volume>34</volume><fpage>557</fpage><lpage>561</lpage><pub-id pub-id-type="doi">10.1099/0022-1317-34-3-557</pub-id><pub-id pub-id-type="pmid">323417</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tellinghuisen</surname> <given-names>TL</given-names></name><name><surname>Marcotrigiano</surname> <given-names>J</given-names></name><name><surname>Rice</surname> <given-names>CM</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase</article-title><source>Nature</source><volume>435</volume><fpage>374</fpage><lpage>379</lpage><pub-id pub-id-type="doi">10.1038/nature03580</pub-id><pub-id pub-id-type="pmid">15902263</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terwilliger</surname> <given-names>TC</given-names></name><name><surname>Grosse-Kunstleve</surname> <given-names>RW</given-names></name><name><surname>Afonine</surname> <given-names>PV</given-names></name><name><surname>Moriarty</surname> <given-names>NW</given-names></name><name><surname>Zwart</surname> <given-names>PH</given-names></name><name><surname>Hung</surname> <given-names>LW</given-names></name><name><surname>Read</surname> <given-names>RJ</given-names></name><name><surname>Adams</surname> <given-names>PD</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Iterative model building, structure refinement and density modification with the PHENIX AutoBuild wizard</article-title><source>Acta Crystallographica Section D Biological Crystallography</source><volume>64</volume><fpage>61</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1107/S090744490705024X</pub-id><pub-id pub-id-type="pmid">18094468</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vialat</surname> <given-names>P</given-names></name><name><surname>Billecocq</surname> <given-names>A</given-names></name><name><surname>Kohl</surname> <given-names>A</given-names></name><name><surname>Bouloy</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>The S segment of rift valley fever phlebovirus (Bunyaviridae) carries determinants for attenuation and virulence in mice</article-title><source>Journal of Virology</source><volume>74</volume><fpage>1538</fpage><lpage>1543</lpage><pub-id pub-id-type="doi">10.1128/JVI.74.3.1538-1543.2000</pub-id><pub-id pub-id-type="pmid">10627566</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vranken</surname> <given-names>WF</given-names></name><name><surname>Boucher</surname> <given-names>W</given-names></name><name><surname>Stevens</surname> <given-names>TJ</given-names></name><name><surname>Fogh</surname> <given-names>RH</given-names></name><name><surname>Pajon</surname> <given-names>A</given-names></name><name><surname>Llinas</surname> <given-names>M</given-names></name><name><surname>Ulrich</surname> <given-names>EL</given-names></name><name><surname>Markley</surname> <given-names>JL</given-names></name><name><surname>Ionides</surname> <given-names>J</given-names></name><name><surname>Laue</surname> <given-names>ED</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>The CCPN data model for NMR spectroscopy: development of a software pipeline</article-title><source>Proteins: Structure, Function, and Bioinformatics</source><volume>59</volume><fpage>687</fpage><lpage>696</lpage><pub-id pub-id-type="doi">10.1002/prot.20449</pub-id><pub-id pub-id-type="pmid">15815974</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walter</surname> <given-names>CT</given-names></name><name><surname>Barr</surname> <given-names>JN</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Recent advances in the molecular and cellular biology of bunyaviruses</article-title><source>Journal of General Virology</source><volume>92</volume><fpage>2467</fpage><lpage>2484</lpage><pub-id pub-id-type="doi">10.1099/vir.0.035105-0</pub-id><pub-id pub-id-type="pmid">21865443</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kabsch</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>XDS</article-title><source>Acta Crystallographica. Section D, Biological Crystallography</source><volume>66</volume><fpage>125</fpage><lpage>132</lpage><pub-id pub-id-type="doi">10.1107/S0907444909047337</pub-id><pub-id pub-id-type="pmid">20124692</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yadani</surname> <given-names>FZ</given-names></name><name><surname>Kohl</surname> <given-names>A</given-names></name><name><surname>Préhaud</surname> <given-names>C</given-names></name><name><surname>Billecocq</surname> <given-names>A</given-names></name><name><surname>Bouloy</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>The carboxy-terminal acidic domain of Rift Valley Fever virus NSs protein is essential for the formation of filamentous structures but not for the nuclear localization of the protein</article-title><source>Journal of Virology</source><volume>73</volume><fpage>5018</fpage><lpage>5025</lpage><pub-id pub-id-type="pmid">10233964</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="SA1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.29236.024</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Kuriyan</surname><given-names>John</given-names></name><role>Reviewing Editor</role><aff><institution>University of California, Berkeley</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.</p></boxed-text><p>Thank you for submitting your article &quot;Rift Valley fever virus NSs protein core domain structure suggests molecular basis for pathogenic nuclear filaments&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by John Kuriyan as the Senior Editor and Reviewing Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Yorgo Modis (Reviewer #1); Jason Mclellan (Reviewer #2), Richard J Kuhn (Reviewer #3).</p><p>In this study Barski et al. describe the crystal structure of the non-structural protein NSs from Rift Valley fever virus (RVFV) of the Bunyaviridae. NSs is an important virulence factor that impedes interferon production by at least three mechanisms: binding to the p44 subunit of TFIIH; binding to SAP30; and targeting the RNA-dependent protein kinase PKR for degradation. Moreover, RVFV NSs forms nuclear filaments, which have been reported to associate with pericentromeric DNA, potentially causing chromosomal segregation defects.</p><p>The authors identified a soluble monomeric fragment of NSs using gel filtration and NMR. The 2.2 Å structure of the NSs core was determined by phasing with sulfur anomalous signals, and was found to be a novel fold consisting of 8 α-helices. In the crystal, NSs forms two types of fibrils, each with two-start helical symmetry. The authors demonstrated that these fibrils have diameters similar to those observed by thin-section EM in Vero-E6 cells infected with RVFV. Immunofluorescence microscopy showed that RVFV containing the crystallized fragment of NSs formed similar nuclear filaments as wild-type RVFV. However, viruses containing an NSs gene with either of two structure-based mutations aimed at disrupting the &quot;F1&quot;-type fibril-forming contacts did not form any nuclear filaments in infected cells. The viruses bearing the mutant proteins grew to similar titers and had similar plaque morphologies as the wild-type. The authors conclude that the F1 fibril-forming interface in the crystal (the stronger of the two interfaces) corresponds to the physiological interface responsible for NSs filament formation during RVFV infection. The authors note that the N- and C-terminal tails containing putative protein interaction regions, including the putative SAP30 interaction region, are exposed on the surface of F1 NSs fibrils.</p><p>This manuscript is clear and very well written. The structural studies are excellent, as is the analysis of the fibrils found in the lattice. The figures are clear, and they helped to convey the three-dimensional lattice and fibril interactions. The structure of the RVFV bunyaviral NSs protein is important and will help the field better understand the function of this key virulence factor. The identification of a soluble and crystallizable NSs fragment that can form physiologically relevant fibril contacts in the crystal is a technical achievement.</p><p>The reviewers recognize that a weakness of this study is that it does not address the question of whether filament formation is important for NSs function. The authors speculate that the NSs fibrils may promote infection by sequestering NSs binding partners, but it remains unclear whether NSs filaments have any proviral activity beyond that of soluble NSs. Indeed, the finding that the NSs-mutant RVFVs do not form NSs filaments but have the same infectivity as wild-type virus in cell culture, and the lack of conservation of fibril-forming residues in NSs in other phleboviruses (despite predicted conservation of the overall fold of NSs in the genus), suggest that NSs filament formation may not play a fundamental role in the viral replication cycle. Additionally, although the site-directed mutagenesis lends support to the authors' conclusion that the F1 fibrils represent the architecture of NSs filaments in vivo, the data do not rule out the possibility that the native full-length NSs filaments have an alternative conformation in vivo. While recognizing these limitations of the present work, we have concluded that the paper represents a sufficient level of new information concerning this important virus for publication in <italic>eLife</italic>.</p><p>Major Comment:</p><p>Given the reservations expressed above, we ask that the title be modified to remove the adjective &quot;pathogenic&quot; with regard to the nuclear filaments. In addition, we also ask that the Discussion section of the paper be edited to bring up the limitations of the study, as discussed above, making it clear to the reader that the relevance of the fibrils for diseases causation remains to be established. We note that the structural information provided here should facilitate such studies, a point that the authors could make to balance the principal weakness of the work, while not ignoring that weakness.</p><p>Other comments to address:</p><p>1) What is the rationale for naming the tetramers T1-T4? Since T1 and T3 are discussed at length and have a broadly similar more planar arrangement, it would seem preferable to rename T3 to T2, use T3 and T4 for the non-planar tetramers that are discussed less (currently T2 and T4).</p><p>2) Subsection “NSs-ΔNΔC in the crystal forms helical fibrils that are stabilized by extensive interfaces”, end of first paragraph. High B-factors do not necessarily reflect conformational instability of a crystallized component.</p><p>3) Discussion, ninth paragraph. This section of the Discussion is simply restating the results and should be deleted or shortened significantly.</p><p>4) Discussion, sixth paragraph: change &quot;almost inevitable&quot; to &quot;likely&quot; (or similar).</p><p>5) <xref ref-type="fig" rid="fig3">Figure 3C</xref>. The panel on the right is very effective.</p><p>6) <xref ref-type="fig" rid="fig6">Figure 6</xref>. In certain views (e.g. certain bottom panel) the NSs filaments have the appearance of a flattened ribbon or sheet rather than a string or worm-shaped filament. The details of the filament assembly may be worth looking at in greater detail.</p><p>7) <xref ref-type="fig" rid="fig8">Figure 8</xref>. This figure does not convey any information that cannot be conveyed in words and the modeled C-terminal tails could be confusing to some readers. The figure could be deleted (or moved to the supplement).</p><p>8) <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>. The figure would be more effective if the view were rotated to move the axis of the gray rods closer to perpendicular to the paper. Also, the more widely used wall-eye stereo view should be used instead of cross-eye.</p><p>9) Introduction, last paragraph: should &quot;stabilize&quot; be &quot;destabilize&quot;?</p><p>10) Subsection “Crystal structure shows the NSs core domain adopts a novel fold”, first paragraph: include &quot;resolution&quot; or &quot;Bragg spacing&quot; after 2.2 Å.</p><p>11) Subsection “Crystal structure shows the NSs core domain adopts a novel fold”, first paragraph, <xref ref-type="table" rid="table1">Table 1</xref>, and elsewhere: the &quot;P&quot; in P6422 should be italicized.</p><p>12) <xref ref-type="fig" rid="fig2">Figure 2</xref> legend: It is stated that the protein chain is colored in a blue-to-red spectrum, but it would be more accurate to state that it is colored as a rainbow. A blue-to-red spectrum could just be blue-purple-red.</p><p>13) Introduction, first paragraph: &quot;requiring urgent attention&quot; was already mentioned in the same sentence and should be deleted.</p><p>14) – Introduction, fourth paragraph: mention that this protein is an ORFan therefore having limited sequence similarity. Do the other Phleboviruses use these proteins and how related are they within the Bunya's?</p><p>15) Subsection “Crystal structure shows the NSs core domain adopts a novel fold”, second paragraph: – – it would be nice to mention the molecular mass of the protein somewhere.</p><p>16) <xref ref-type="fig" rid="fig2">Figure 2</xref>. – Include the numbers and the N and C termini distinctions in the picture of the structure.</p></body></sub-article><sub-article article-type="reply" id="SA2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.29236.025</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Major Comment:</p><p>Given the reservations expressed above, we ask that the title be modified to remove the adjective &quot;pathogenic&quot; with regard to the nuclear filaments. In addition, we also ask that the Discussion section of the paper be edited to bring up the limitations of the study, as discussed above, making it clear to the reader that the relevance of the fibrils for diseases causation remains to be established. We note that the structural information provided here should facilitate such studies, a point that the authors could make to balance the principal weakness of the work, while not ignoring that weakness.</p></disp-quote><p>The title was changed as suggested. We added a statement to the end of the Discussion to highlight that this study did not attempt to establish a role of NSs filament formation for pathogenicity, and that this is a clear limitation of our work. Establishing the role of filament formation for virulence, which may require animal models, is beyond the scope of our structural and cell-based approach. For instance the observation of similar plaque sizes caused by virus variants studied here does not shed light on the role of NSs filaments in pathogenesis, since NSs protein is not required for viral replication and cell infection. However lack of NSs results in loss of virulence in animal models. We believe the structural data and insight into the molecular determinants of NSs polymerization will greatly facilitate future studies aimed at understanding the role of NSs filaments. It will help answering the questions why RVFV appears to be the only virus inducing such filaments, and if this is in any way linked with the unique spectrum of pathologies associated with RVFV infections, in particular fetal deformities and abortions, which are a hallmark of RVFV.</p><disp-quote content-type="editor-comment"><p>Other comments to address:</p><p>1) What is the rationale for naming the tetramers T1-T4? Since T1 and T3 are discussed at length and have a broadly similar more planar arrangement, it would seem preferable to rename T3 to T2, use T3 and T4 for the non-planar tetramers that are discussed less (currently T2 and T4).</p></disp-quote><p>There was no particular rationale behind numbering the tetramers. As suggested the tetramers have been renamed in the text and figures. Also NSs protein and virus variants previously named “muT2” have been renamed “muT3” to reflect mutations affecting the interface of the (now) T3 tetramer.</p><disp-quote content-type="editor-comment"><p>2) Subsection “NSs-ΔNΔC in the crystal forms helical fibrils that are stabilized by extensive interfaces”, end of first paragraph. High B-factors do not necessarily reflect conformational instability of a crystallized component.</p></disp-quote><p>We agree, however B factors in a crystal assembly do reflect the quality of packing, or the definition of interfaces. A lower degree of order within an interface would make this interface less stable. We have changed the text to avoid any ambiguity, and added a reference to highlight that B factors have been used to distinguish biological interfaces from packing artifacts.</p><disp-quote content-type="editor-comment"><p>3) Discussion, ninth paragraph. This section of the Discussion is simply restating the results and should be deleted or shortened significantly.</p></disp-quote><p>This section was shortened significantly.</p><disp-quote content-type="editor-comment"><p>4) Discussion, sixth paragraph: change &quot;almost inevitable&quot; to &quot;likely&quot; (or similar).</p></disp-quote><p>Changed as suggested.</p><disp-quote content-type="editor-comment"><p>5) <xref ref-type="fig" rid="fig3">Figure 3C</xref>. The panel on the right is very effective.</p></disp-quote><p>Thank you.</p><disp-quote content-type="editor-comment"><p>6) <xref ref-type="fig" rid="fig6">Figure 6</xref>. In certain views (e.g. certain bottom panel) the NSs filaments have the appearance of a flattened ribbon or sheet rather than a string or worm-shaped filament. The details of the filament assembly may be worth looking at in greater detail.</p></disp-quote><p>The appearance of filaments in the immunostaining images is most likely an artifact of microscopy of large structures occupying many focal planes; it depends on the choice of focal plane. Data presented here do not allow conclusions about the three-dimensional shape of the filaments, which we agree deserves attention in the future.</p><disp-quote content-type="editor-comment"><p>7) <xref ref-type="fig" rid="fig8">Figure 8</xref>. This figure does not convey any information that cannot be conveyed in words and the modeled C-terminal tails could be confusing to some readers. The figure could be deleted (or moved to the supplement).</p></disp-quote><p>We believe the figure is not essential for the paper, but useful for highlighting how a full-length NSs fibril might be based on the NSs-ΔNΔC core fibril. The C-terminal tails have been shown to be natively unfolded, and therefore adding them to the fibril model as extended randomly oriented extensions is justifiable. The figure is now a supplementary figure (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>).</p><disp-quote content-type="editor-comment"><p>8) <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>. The figure would be more effective if the view were rotated to move the axis of the gray rods closer to perpendicular to the paper. Also, the more widely used wall-eye stereo view should be used instead of cross-eye.</p></disp-quote><p>We improved the figure so the gray rods align better with the fibrils, and changed to wall-eye stereo.</p><disp-quote content-type="editor-comment"><p>9) Introduction, last paragraph: should &quot;stabilize&quot; be &quot;destabilize&quot;?</p></disp-quote><p>Changed to make this statement unambiguous.</p><disp-quote content-type="editor-comment"><p>10) Subsection “Crystal structure shows the NSs core domain adopts a novel fold”, first paragraph: include &quot;resolution&quot; or &quot;Bragg spacing&quot; after 2.2 Å.</p></disp-quote><p>Done.</p><disp-quote content-type="editor-comment"><p>11) Subsection “Crystal structure shows the NSs core domain adopts a novel fold”, first paragraph, <xref ref-type="table" rid="table1">Table 1</xref>, and elsewhere: the &quot;P&quot; in P6422 should be italicized.</p></disp-quote><p>Done.</p><disp-quote content-type="editor-comment"><p>12) <xref ref-type="fig" rid="fig2">Figure 2</xref> legend: It is stated that the protein chain is colored in a blue-to-red spectrum, but it would be more accurate to state that it is colored as a rainbow. A blue-to-red spectrum could just be blue-purple-red.</p></disp-quote><p>Done, also changed in the figure legend for <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>.</p><disp-quote content-type="editor-comment"><p>13) Introduction, first paragraph: &quot;requiring urgent attention&quot; was already mentioned in the same sentence and should be deleted.</p></disp-quote><p>Done.</p><disp-quote content-type="editor-comment"><p>14) Introduction, fourth paragraph: mention that this protein is an ORFan therefore having limited sequence similarity. Do the other Phleboviruses use these proteins and how related are they within the Bunya's?</p></disp-quote><p>This is addressed in the fourth paragraph of the Introduction and in the ninth paragraph of the Discussion. We expanded the relevant section in the Introduction to highlight sequence diversity and the limited knowledge of NSs protein functions and mechanisms.</p><disp-quote content-type="editor-comment"><p>15) Subsection “Crystal structure shows the NSs core domain adopts a novel fold”, second paragraph: it would be nice to mention the molecular mass of the protein somewhere.</p></disp-quote><p>Done.</p><disp-quote content-type="editor-comment"><p>16) <xref ref-type="fig" rid="fig2">Figure 2</xref>. Include the numbers and the N and C termini distinctions in the picture of the structure.</p></disp-quote><p>Done.</p></body></sub-article></article>